Page last updated: 2024-08-18

cyclohexanol and Depressive Disorder

cyclohexanol has been researched along with Depressive Disorder in 413 studies

Research

Studies (413)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (0.24)	18.7374
1990's	144 (34.87)	18.2507
2000's	202 (48.91)	29.6817
2010's	66 (15.98)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Filov, I; Gerazova, VP; Marinov, P; Novotni, A; Ristevska-Dimitrovska, G; Shishkov, R; Stefanovski, B; Vujovik, V	1
Groot, PC	1
Al Hadithy, AF; Birkenhager, TK; Koch, BC	1
Veltishchev, DY	1
Cooper, N; Gross, JJ; McRae, K; Rekshan, W; Williams, LM	1
Becker, T; Kösters, M; Staudigl, L	1
Bisaga, A; Glass, A; Kelly, MA; Levin, FR; Mariani, JJ; Nunes, EV; Pavlicova, M; Sullivan, MA	1
Arnow, BA; Boyce, PM; Day, CV; DeBattista, C; Etkin, A; Harris, AW; John Rush, A; Rekshan, W; Schatzberg, AF; Williams, LM	1
Arnow, BA; Blasey, C; Etkin, A; Kulkarni, J; Luther, JF; Palmer, DM; Rekshan, W; Rush, AJ; Schatzberg, AF; Williams, LM	1
Artama, M; Engeland, A; Furu, K; Gissler, M; Haglund, B; Kieler, H; Malm, H; Nørgaard, M; Selmer, R; Stephansson, O; Valdimarsdottir, UA; Zoega, H	1
Dolman, C; Howard, LM; Khalifeh, H	1
McMahon, FJ	1
Gavrilova, SI; Kalyn, YB; Kornilov, VV; Safarova, TP; Sheshenin, VS; Shipilova, ES; Yakovleva, OB	1
Sher, L	1
Balcioglu, I; Bayar, R; Dalkiran, M; Emul, M; Keles, I; Samim, S; Yildirim, E	1
Birkenhäger, TK; Bruijn, JA; Mulder, PG; Pluijms, E; van den Broek, WW; van Os, E	1
Casillas-Lara, L; Rueda-Villar, T; Ruiz-Doblado, S	1
Pearlstein, T	1
Allgulander, C; Nutt, D	1
Lugoboni, F; Quaglio, G; Schifano, F	1
Thase, ME	8
Vitiello, B	1
Ara, A; Banu, N; Zafir, A	1
Aslan, E; Başterzi, AD; Delialioğlu, N; Taşdelen, B; Tot Acar, S; Yazici, A; Yazici, K	1
Diaz-Rojas, J; Einarson, TR; Jaramillo, LE; Lopera, MM; Machado, M	1
Hardy-Baylé, MC; Passerieux, C	1
Chan, JH; Chen, CH; Robson, D; Tan, HK	1
Asarnow, JR; Birmaher, B; Brent, D; Clarke, G; DeBar, L; Emslie, G; Iyengar, S; Keller, M; Kennard, B; Leonard, H; Mayes, T; McCracken, J; Porta, G; Ritz, L; Ryan, N; Shamseddeen, W; Spirito, A; Strober, M; Suddath, R; Vitiello, B; Wagner, KD	1
Caltagirone, C; Cravello, L; Spalletta, G	1
Andersohn, F; Garbe, E; Schade, R; Suissa, S	1
Weissman, MM	1
Hassan, M; Marcus, SC; Olfson, M	1
Arellano, J; Baird, J; Benedict, A; De Cock, E	1
Smith, E	1
Bakish, D	2
Birkenhäger, TK; Boks, MP; Breteler, LM; Bruijn, JA; Burger, H; Janzing, JG; Nolen, WA; Ramaekers, GM; van den Broek, WW; van der Loos, ML; Verkes, RJ; Wijkstra, J	1
Arnheim, K	1
Anghelescu, IG; Dierkes, W; Loeschmann, PA; Schmitt, AB; Volz, HP	1
Garg, R; Gaur, V; Kumar, A; Kumar, P	1
Birmaher, B; Brent, D; Clarke, G; DeBar, L; Devlin, B; Emslie, G; Ferrell, R; Keller, M; Mayes, T; Melhem, N; Onorato, M; Ryan, N; Vitiello, B; Wagner, KD; Zelazny, J	1
Benedetti, F; Bernasconi, A; Colombo, C; Dallaspezia, S; Radaelli, D; Smeraldi, E	1
Andersen, CL; Videbech, P	1
Masand, PS; Pae, CU; Patkar, AA; Seo, HJ; Sohi, MS	1
Assimes, TL; Dell'aniello, S; Martinez, C; Mines, D; Suissa, S	1
Taylor, D	1
Desmarais, JE; Looper, KJ	1
Bach, A; Deuschle, M; Feuerhack, A; Frankhauser, P; Gilles, M; Hamann, B; Kopf, D; Lederbogen, F; Onken, V; Scharnholz, B; Schilling, C	1
Osterfeld, ND; Uttner, I; Wolf, RC	1
Begré, S; Gerber, M; Traber, M; von Känel, R	2
Asarnow, JR; Birmaher, B; Brent, D; Clarke, G; DeBar, L; Emslie, GJ; Iyengar, S; Keller, M; Kennard, B; Mayes, T; McCracken, J; Onorato, M; Porta, G; Ryan, N; Spirito, A; Strober, M; Vitiello, B; Wagner, KD; Zelazny, J	1
Bérard, A; Broy, P; Nakhai-Pour, HR	1
Ghosh, A; Grover, S; Shah, R	1
Agius, M; Gardner, J; Liu, K; Zaman, R	3
Agius, M; Davis, A; Gilhooley, M; Zaman, R	1
Bi, X; Fang, S; He, J; Kong, J; Li, XM; Wang, D; Wu, J; Xu, H; Yan, B; Yang, Y; Zhang, Y	1
Hackett, LP; Ilett, KF; Kohan, R; Teoh, S; Watt, F	1
Del Casale, A; Girardi, P; Innamorati, M; Lester, D; Mancini, M; Pompili, M; Serafini, G; Tatarelli, R	1
Baillés, E; Bargalló, N; Boget, T; Carreño, M; Donaire, A; Matrai, S; Pintor, L; Rumia, J; Setoain, X	1
Rueda-Villar, T; Ruiz-Doblado, S; Sanz-Cortes, S; Zurita-Gotor, P	1
Fuertes, L; García-Cano, I; Ortiz de Frutos, J; Vanaclocha, F	1
Macaluso, M; Preskorn, SH	1
Becker, T; Jin, WD; Koesters, M; Ma, YC; Weinmann, S; Zhang, Y	1
Ciszowski, K; Gawlikowski, T; Krzyzanowska-Kierepka, E; Szpak, D	1
Fulda, S; Himmerich, H; Plümäkers, B; Rink, L; Sheldrick, AJ	1
Aubry, JM; Bertschy, G; Bondolfi, G; Gex-Fabry, M; Kosel, M; Malafosse, A; Perroud, N; Uher, R	1
Bobo, WV; Chen, H; Cook, IA; Fava, M; Husain, MM; Kornstein, SG; Kurian, BT; Lesser, IM; Luther, JF; Morris, DW; Nierenberg, AA; Rush, AJ; Shelton, RC; Stewart, JW; Trivedi, MH; Warden, D; Wisniewski, SR	1
Cassano, GB; Mula, M; Pini, S; Preve, M	1
Asarnow, JR; Berk, M; Birmaher, B; Brent, DA; Clarke, G; Emslie, G; Keller, M; Mayes, T; McCracken, J; Porta, G; Spirito, A; Vitiello, B; Wagner, KD	1
Dusetzina, SB; Ellis, AR; Farley, JF; Gaynes, BN; Hansen, RA; Miller, WC; Stürmer, T	1
Ananiev, J; Cardoso, J; Kupcova, G; Sucha, N; Tchernev, G; Trafeli, J	1
Davis, LL; Fava, M; Friedman, ES; Rush, AJ; Trivedi, MH; Wisniewski, SR; Zisook, S	1
Kostek, H; Kujawa, A; Majewska, M; Pyra, E; Szponar, J	1
Lee, KU; Lee, YM	1
Seeger, J; Strombom, I; Turnbull, B; Xue, F; Zhu, S	1
Dahmen, N; Engel, A; Gerbaulet, M; Hiemke, C	1
Avari, J; Mahgoub, N	1
Rittmannsberger, H; Werl, R	1
Bech, P; Lunde, M; Martiny, K; Plenge, P	1
Friedman, JH; Weintraub, D	1
Black, KJ; Brodsky, M; Christine, CW; Como, PG; Elmer, L; Factor, SA; Fernandez, HH; Horn, S; Hyson, HC; Jiang, W; Juncos, J; Kurlan, R; Lyness, JM; Manning, C; Marsh, L; McDermott, MP; McDonald, W; Panisset, M; Pearson, N; Pfeiffer, R; Press, D; Richard, IH; Rottenberg, D; Serrano Ramos, C; Shulman, L; Singer, C; Slevin, J	1
Frank, D; Janssens, U; Meyer, I	1
Delagrange, P; Elizalde, N; García-García, AL; Tordera, RM; Venzala, E	1
Bahk, WM; Jun, TY; Jung, YE; Song, HR; Wang, HR; Woo, YS	1
Steiner, M	1
Barrera, M; Feldman, B; Koren, G; Nulman, I; Pulver, A; Rovet, J; Streiner, D	1
Blanch, B; Friend, P; Gilfillan, D; Graham, RK; Hadzi-Pavlovic, D; Manicavasagar, V; Parker, G; Paterson, A; Perich, T; Sheppard, E; Synnott, H	1
Adams, J; Graves, N; Solomon, D	1
Andrade, L; Artes, R; Gorenstein, C; Moreno, RA	1
De Bleeker, E; De Nayer, A; Evrard, JL; Fossion, P; Geerts, S; Leyman, S; Linkowski, P; Mignon, A; Ruelens, L; Schittecatte, M; Van Eeckhoutte, I	1
Cohen, NL; Kennedy, SH; Lam, RW; Wan, DD	1
Argyropoulos, S; Hardy, J; Nutt, DJ	1
Anghelescu, I; Dahmen, N; Klawe, C	1
Sageman, S	1
Benkert, O; Muller, M; Szegedi, A	1
Entsuah, R; Hackett, D; Silverstone, PH	1
Mbaya, P	1
Lin, HN; Shang, CY; Soong, WT	1
Bobkiewicz-Kozłowska, T; Kus, K; Nowakowska, E	1
Entsuah, R; Rudolph, RL; Stahl, SM	1
Rudolph, RL	1
Pan, JJ; Shen, WW	1
Barnes, A; Davies, J; Jones, IK; Lloyd, KR; Pilowsky, LS	1
Hazell, P	2
Briley, M	1
Howe, C; Ravasia, S	1
Adamou, M; Hale, AS	1
Chen, J; Entsuah, AR; Mallick, R; Schatzberg, AF	1
Stewart, DE	2
Dawson, LA; Li, P	1
Frampton, C; Joyce, PR; Mulder, RT; Porter, R	1
Iraqi, AH	1
Akdeniz, F; Donat, O; Gonul, AS; Vahip, S	1
Datto, CJ; DiFilippo, S; Katz, IR; Oslin, DW; Streim, JE; Ten Have, TR; Weintraub, D	1
Aiso, JY; Gutierrez, MA; Stimmel, GL	1
Dierkes, W; Linden, M; Ludewig, K; Munz, T	1
Lenox-Smith, AJ; Reynolds, A	1
Aït-Ameur, A; Bertschy, G; Favre, S; Muscionico, M; Ragama-Pardos, E; Roth, L	1
Amsterdam, JD; Brunswick, DJ	1
Iodice, AJ; McCall, WV	1
Nemeroff, CB	2
Balant, LP; Balant-Gorgia, AE; Bertschy, G; Gex-Fabry, M; Rudaz, S; Veuthey, JL	1
Burrows, GD; Norman, TR; Olver, JS	1
Fontes, CL; Geissler, EC; Harada, AS; Wan, GJ; Yu-Isenberg, KS	1
Arango, V; Basavarajappa, BS; Cooper, TB; Hungund, BL; Kassir, SA; Mann, JJ; Vinod, KY; Yalamanchili, R	1
Houlihan, DJ	1
Basta-Kaim, A; Bosmans, E; Budziszewska, B; Kajta, M; Kenis, G; Kubera, M; Maes, M; Scharpe, S	1
Burns, RB; Hartman, EE	1
Eisner, M; Hopayian, K; Laurence, M	1
Burke, WJ	1
Kavirajan, H	1
Bothmer, J; Huusom, AK; Montgomery, SA	1
Alamo, C; López-Muñoz, F; Rubio, G; San, L	1
Hindmarch, I; Rigney, U; Stanley, N; Trick, L	1
Ferrier, N; Harrison, CL; Young, AH	1
Hansen, LK	1
Karp, JF	1
Delgado, PL	1
Chand, PK; Kalyani, GS; Murthy, P	1
Bielski, RJ; Chang, CC; Ventura, D	1
Demitrack, MA	1
Bertolín-Guillén, JM; Climent-Díaz, B; Navarré-Gimeno, A	1
Aït-Ameur, A; Bertschy, G; Ferrero, F; Muscionico, M; Osiek, C; Ragama-Pardos, E; Roth, L	1
Mazeh, D; Melamed, Y; Saraf, R; Shahal, B	1
Baumann, P; Brawand-Amey, M; Brocard, M; Ciusani, E; Eap, CB; Zullino, DF	1
Liappas, J; Paparrigopoulos, T; Rabavilas, A; Tzavellas, E	1
Hsiao, MC; Lin, YH; Liu, CY	1
Benson, BE; Dunn, RT; Ketter, TA; Kimbrell, TA; Little, JT; Luckenbaugh, DA; Post, RM; Willis, MW	1
Alevizos, B; Alevizos, E; Vaidakis, N	1
Florkowski, A; Gałecki, P; Kołodziejska, I; Nowakowski, T; Pawełczyk, A; Pietras, T; Zboralski, K	1
Hemels, ME; Toumi, I; Wade, AG	1
Baldomero, EB; Calvo, CG; Cercós, CL; López, RP; Ruiloba, JV; Ubago, JG	1
Ladd, CO; Loughhead, A; Newport, DJ; Ragan, KA; Stowe, ZN	1
Carpenter, D; Connor, K; Davidson, J; Krishnan, R; Krulewicz, S; Nemeroff, C; Owens, M; Watkins, L	1
Florkowski, A; Gałecki, P; Gruszczyński, W; Kołodziejska, I; Mikołajczyk, I; Zboralski, K	1
Cavanagh, J; Dempsey, MF; Dewar, D; Eersels, J; Patterson, J; Pimlott, S; Wyper, D	1
Greiner, W; Kulp, W; von der Schulenburg, JM	1
Botts, S	1
Lang, AE; Voon, V	1
Baca, E; Garcia-Calvo, C; Prieto, R; Roca, M	1
Papadimitriou, GN; Psarros, C; Sakkas, P; Soldatos, CR; Theleritis, CG	1
Chen, Z; Dyck, L; Haimanot, S; He, J; Li, X; Li, XM; Xu, H	1
Altshuler, LL; Denicoff, KD; Frye, MA; Grunze, H; Keck, PE; Kitchen, CM; Kupka, RW; Leverich, GS; McElroy, S; Mintz, J; Nolen, WA; Post, RM; Suppes, T; Walden, J	1
Gregoriou, S; Kalogeromitros, D; Papadimitriou, GN; Papageorgiou, CC; Rabavilas, AD; Syrigou, E; Theleritis, CG	1
Krol, DG; Nolen, WA	1
Arneth, B; Dragicevic, A; Härtter, S; Hiemke, C; Kaiser, R; Lackner, K; Müller, MJ; Shams, ME	1
Butler, R; Carney, S; Cipriani, A; Geddes, J; Hatcher, S; Price, J; Von Korff, M	1
Cornwall, L; Foran, K; Forrest, S; Ingram, G; McAllister-Williams, RH; McMahon, L; Rajwal, M; Taylor, M	1
Malek-Ahmadi, P; Prabhu, F	1
Cornwall, PL; Foran, K; Forrest, S; Ingram, G; McAllister-Williams, RH; McMahon, L; Rajwal, MS; Taylor, M	1
Agogué, C; Bérard, A; Carceller, AM; Ferreira, E; Francoeur, D; Martin, BZ; St-André, M	1
Alexopoulos, GS; Carpenter, D; Docherty, JP; Katz, IR; Reynolds, CF	1
Fernández, AS; López-García, P; Navarro, JS; Sádaba, B; Santos, PM; Vidal, JP	1
Akinpeloye, HO; Hamzah, Z; Hannan, N; Meagher, D	1
Mulsant, BH	1
Ghaemi, SN; Wingo, AP	1
Field, M; Hibbert, E; Roxanas, M	1
Araya, AV; Fiedler, JL; Fritsch, R; Gatica, H; Herrera, L; Rojas, G; Rojas, P; Rojas, R; Silva, H	1
Heerdink, ER; van Dijk, L; Volkers, AC	1
Bravo-Mehmedbasić, A; Kucukalić, A; Kulenović, AD; Suljić-Mehmedika, E	1
Dubarek, W; Kucia, K	1
Ligtenberg, JJ; Meertens, JH; Monteban-Kooistra, WE; Tulleken, JE; Zijlstra, JG	1
Heeren, T; Kok, R; Nolen, W	1
Ahmed, S; Dunner, DL; Ferguson, JM; Friedman, ES; Gelenberg, AJ; Hirschfeld, RM; Keller, MB; Kocsis, JH; Kornstein, SG; Musgnung, J; Nemeroff, CB; Ninan, PT; Pedersen, RD; Rothschild, AJ; Schatzberg, AF; Shelton, RC; Thase, ME; Trivedi, MH; Yan, B; Zajecka, JM	1
Spindler, PE	1
Bolaman, Z; Kadikoylu, G; Yavasoglu, I	1
Bares, M; Cerná, L; Kopecek, M; Raszka, M; Seifertová, D; Sulak, J	1
Ekman, M; Jönsson, B; Khandker, R; Ovanfors, A; Sobocki, P	1
Berk, M; Malhi, GS; Ng, F	1
Amsterdam, JD; Shults, J	1
Carpenter, DJ; Krulewicz, S; Nemeroff, CB; Owens, MJ; Plott, SJ; Sheehan, DV; Simon, JS; Thase, ME	1
Kornstein, SG	1
Algayres, JP; Béchade, D; Blondon, H; Bonnefoy, S; Carmoi, T; Desramé, J	1
Goldberg, RJ	1
Guelfi, JD; Guichoux, JY; Hackett, D; Magni, G; White, C	1
Danjou, P; Hackett, D	1
Montgomery, SA	1
Lecrubier, Y	1
Mendlewicz, J	1
Preskorn, SH	2
Keltner, NL	1
Cohn, C; Crowder, J; Davidson, J; Dunner, D; Feighner, J; Kiev, A; Patrick, R; Shrivastava, RK	1
Clerc, GE; Ruimy, P; Verdeau-Pallès, J	1
Holdcroft, C	1
Cole, JO; Feighner, JP; Nierenberg, AA; Rudolph, R; Sullivan, J	1
Bradley, MM; Entsuah, AR; Littman, GS	1
Feighner, JP	4
Drevets, WC	1
Cunningham, LA	2
Feighner, J; Mandos, LA; Rickels, K; Schweizer, E	1
Borison, RL; Carman, JS; Chouinard, G; Crowder, JE; Cunningham, LA; Diamond, BI; Fischer, DE; Hearst, E	1
Johnston, R; Mattes, J; Mendels, J; Riesenberg, R	1
Farah, A; Lauer, TE	1
Schulte, H; Songer, DA	1
Leonard, BE	1
Rothschild, AJ	1
Benkert, O; Gründer, G; Schlösser, R; Wetzel, H	1
Arnecke, B; Guidry, JR; Heisler, MA	1
Ballenger, JC	1
Ereshefsky, L	1
Entsuah, AR; Hackett, D; Miska, S; Rudolph, RL	1
Russell, JL	1
Chitra, R; Entsuah, AR; Rudolph, RL	1
Stoudemire, A	1
Dierick, M; Martin, A; Ravizza, L; Realini, R	1
Kirsch, MA; Lannon, RA; Lewis, TB; Louie, AK	1
Benson, B; Danielson, A; Ketter, TA; Kimbrell, TA; Little, JT; Post, RM; Willis, MW	1
Bailey, P; Danjou, PH; Guichoux, JY; Hackett, D; Luthringer, R; Macher, JP; Schaltenbrand, N; Toussaint, M	1
Clark, A; Livingston, MG	1
Kohn, S; Labbate, LA	1
Cavanaugh, GL; Martin, RE; Robinson, DD; Stenson, MA	1
Duman, RS; Heninger, GR; Malison, RT; Nestler, EJ; Price, LH	1
Michael, A; Owen, A	1
Möller, HJ; Volz, HP	1
Mandoki, MW; Parker, JL; Sumner, GS; Tapia, MA; Tapia, MR	1
Andrews, JM; Nemeroff, CB; Ninan, PT	1
Garber, A; Gregory, RJ	1
de Koning, FH; Egberts, AC; Lenderink, AW; Leufkens, HG	1
Gupta, AK; Saravay, SM	1
Franzoni, S; Ranieri, P; Rozzini, R; Trabucchi, M	1
Benazzi, F	6
Adès, J; Lejoyeux, M	1
Frazer, A	1
Nelson, JC	2
Hesselink, JK; Panagides, J; Pinder, R; Sambunaris, A; Stahl, SM	1
Jenkins, P; Wilson, R	1
Hackett, D; Mahapatra, SN	1
Bagby, RM; Dickens, SE; Joffe, R; Kennedy, SH; Levitt, A; Minifie, CE; Schuller, DR	1
Agelink, MW; Klieser, E; Zitzelsberger, A	1
Alpert, J; Fava, M; Mulroy, R; Nierenberg, AA; Rosenbaum, JF	1
Albano, D; Amchin, J	1
Bourgeois, JA; Walker, D; Zhalkovsky, B	1
Yonkers, KA	1
Davidson, RJ; Irwin, W; Kalin, NH; Lowe, M; Mock, BJ; Orendi, JL; Sorenson, JA; Sutton, SK; Turski, PA; Warner, G	1
Entsuah, R; Khan, A; Leventer, SM; Rudolph, RL; Upton, GV	1
Entsuah, AR; Feighner, JP; McPherson, MK	1
Amsterdam, JD; Garcia-España, F; Goodman, D; Hooper, M; Hornig-Rohan, M	1
Chitra, R; Entsuah, R	1
Donnelly, NJ; Khouzam, HR	1
Derivan, AT; Entsuah, R; Fabre, LF; Feighner, JP; Rickels, K; Rudolph, RL	1
Amore, M; Ferrari, G; Perez, J; Ricci, M; Zanardi, R	1
Chitra, R; Entsuah, R; Rudolph, RL	1
Bhatara, VS; Magnus, RD; Paul, KL; Preskorn, SH	1
Blennerhassett, J; Parker, G	1
Nemeroff, CB; Owen, JR	1
Macbeth, R; Rajagopalan, M	1
Bader, GM; Hawley, JM; Short, DD	1
Amchin, J; Amsterdam, JD; Hooper, MB	1
Boyd, IW	1
Costa e Silva, J	1
Sharma, V	1
Richelson, E	1
Bhatia, SC; Gupta, S; Theesen, KA	1
Joffe, RT; Lee, DK; Marshall, AM	1
Stahl, SM	2
Raby, WN	1
Markowitz, JS; Patrick, KS	1
Agelink, MM; Klieser, E; Zeit, T	1
Batziris, HP; DeSilva, D; Jaffe, PD; McIntyre, IM; van der Hoeven, P	1
Frye, MA; Ketter, TA; Little, JT; Luckenbaugh, D; Mathé, AA; Post, RM	1
Ravindran, A; Silverstone, PH	1
Kirsch, MA; Louie, AK	1
Schatzberg, AF	1
Addis, A; Einarson, TR; Iskedjian, M	1
Hale, MS; Lenderking, WR; Nackley, JF; Tennen, H; Testa, MA; Turner, RR	1
Ferrier, IN	1
Horst, WD; Preskorn, SH	1
Hirschfeld, RM	1
Akyol, A; Bolukbasi, O	1
Birkenhäger, TK; Moleman, P	1
Emamian, ES; Fatemi, SH; Kist, DA	1
Martin, P	1
Boyer, P	1
Gorman, JM	1
Bakish, D; Blier, P; de Montigny, C; Debonnel, G; Silverstone, PH	1
Salzman, C	1
DeVane, CL; Pollock, BG	1
Clouse, J; Frank, RG; Goldman, HH; Griffiths, RI; Herbert, RJ; Strauss, MJ; Sullivan, EM	2
Paton, C	1
Maltese, TM	1
Judge, R; Wagner, BE	1
Boyer, P; Poirier, MF	1
Nierenberg, AA; Wright, EC	1
Ninan, PT	1
Sheehan, DV	2
Franchini, L; Perez, J; Serretti, A; Smeraldi, E; Zanardi, R	1
Feiger, AD; Rudolph, RL	1
Cabras, PL; Cellini, M; Di Bernardo, M; Mannucci, E; Paionni, A; Ricca, V; Rotella, CM	1
Behnke, K; Mehtonen, OP; Roponen, P; Søgaard, J	1
Arrufat, FJ; Baeza, I; Bernardo, M; Navarro, V; Salvà, J	1
Kent, JM	1
Benedictis, E; D'Arrigo Busnello, E; De Campos, JA; De Cassia Rodrigues, RL; Gentil, V; Juruena, MF; Kerr-Correa, F; Lafer, B; Moreno, DH; Moreno, R; Tiosso, A	1
Abbar, M; Blayac, JP; Giniès, E; Peyrière, H; Pinzani, V; Robert, L	1
Connor, TJ; Harkin, A; Kelliher, P; Kelly, JP; Leonard, BE; Shen, Y	1
Farmer, AE; Malhi, GS	1
Dunn, NR; Freemantle, SN; Mackay, FR; Mann, RD; Martin, RM; Pearce, GL	1
Bacchiochi, JR; Bagby, RM; Dickens, SE; Eisfeld, BS; Kennedy, SH	1
Gómez Gómez, JM; Teixidó Perramón, C	1
Haskins, JT; Pollack, MH; Rickels, K; Sheehan, DV	1
Guazzelli, M; Nimatoudis, I; Rizzo, F; Smeraldi, E; Tzanakaki, M; Zissis, NP	1
Ballús, C; Casais, L; De Flores, T; de la Torre, J; Gutiérrez, M; Palao, D; Quiros, G; Riesgo, Y; Rojo, L	1
Amey, M; Baumann, P; Bertel-Laubscher, R; Eap, CB; Zullino, D	1
Blass, DM; Pearson, VE	1
Burrows, G; Johnson, G; Mitchell, PB; Polonowita, A; Schweitzer, I	1
Kleinschmidt, R; Lucht, MJ; Maier, W; Rietschel, M	1
Hackett, D; Samuelian, JC	1
Bell, S; Shipman, M	1
Dijken, WA; Haffmans, J; Hoencamp, E; Huijbrechts, IP	1
Bencomo, L; Bhatia, SC; Bhatia, SK	1
Dugan, D; Ereshefsky, L	1
Davis, GP; Weller, EB; Weller, RA	1
Woods, SW	1
Sheridan, MJ; Wise, TN	1
Hackett, D	1
Caputo, RM; Stern, S; Votolato, NA	1
Fitzgerald, F; Glod, CA; Lynch, A	1
Gorman, JM; Nierenberg, AA; Stahl, SM	1
Blier, P	2
Entsuah, AR; Rudolph, RL; Thase, ME	1
Devarajan, S; Dursun, SM	1
Bosmans, E; Kenis, G; Kubera, M; Lin, AH; Maes, M; van Bockstaele, D	1
Abouesh, AI; Clayton, AH; McGarvey, EL; Pinkerton, RC	1
Prater, JF	1
Kumar, S; Oakley-Browne, M	1
Ansseau, M; Pitchot, W	2
Nierenberg, AA	1
Martin, E; Martin, SD; Rai, SS; Richardson, MA; Royall, R	1
Sackeim, HA	1
Ansseau, M; Guelfi, JD; Kørsgaard, S; Timmerman, L	1
Anghelescu, I; Himmerich, H; Klawe, C; Szegedi, A	1
Linden, M; Ludewig, K; Munz, T	1
Grady-Weliky, TA; Hartmann, DM	1
Salinas, E; Silverstone, PH	1
Ablon, JS; Bouffard, SM; Cohen, LS; Collins, MH; Morabito, C; Nonacs, RM; Viguera, AC	1
Addis, A; Brochu, J; Chambers, C; Einarson, A; Einarson, TR; Fatoye, B; Koren, G; Lavigne, SV; Mastroiacovo, P; Matsui, D; Sarkar, M; Schuler, L	1
Judge, R	1
Joseph, M; McCue, RE	1
Boskailo, E; Durić-Bijedić, Z; Lewis, J; Pavković, I; Smajkić, A; Weine, S	1
Davis, MW; Fisher, AA	1
Kroenke, K	1
Ames, D; Harrigan, S; Kirby, D	1
Anderson, I; Dempster, C; Freemantle, N; Glanville, J; Smith, D	1
Bass, KI; Bolden-Watson, C; Clayton, AH; Croft, HA; Donahue, RM; Jamerson, BD; Leadbetter, RA; Metz, A; Montano, CB; Pradko, JF	1
Linnebur, SA; Pace, WD; Saseen, JJ	1
Culpepper, L	1
Berndt, ER; Crown, WH; Finkelstein, SN; Ling, D; Wan, GJ	1
van Meter, S; Weisler, RH	1
Clary, C; Fox, I; Rickels, K; Schweizer, E; Weise, C	1
Fabre, LF; Khan, A; Rudolph, R	1
Fawcett, J; Guy, C; Zajecka, JM	1
Clary, C; Rickels, K; Schweizer, E; Weise, C	1

Reviews

93 review(s) available for cyclohexanol and Depressive Disorder

Article	Year
[Venlafaxine (velaxin) effectivity in treatment of depression: results of the recent investigations]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2013, Volume: 113, Issue:11 Pt 2 Topics: Cyclohexanols; Depressive Disorder; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2013
[If the general practitioner has to decide: what is the evidence for the selection of antidepressants?]. Deutsche medizinische Wochenschrift (1946), 2014, Volume: 139, Issue:34-35 Topics: Acetamides; Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder; Duloxetine Hydrochloride; Evidence-Based Medicine; General Practice; Germany; Guideline Adherence; Humans; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride	2014
Efficacy of venlafaxine compared with tricyclic antidepressants in depressive disorder: a meta-analysis. Journal of psychopharmacology (Oxford, England), 2009, Volume: 23, Issue:6 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Humans; Odds Ratio; Randomized Controlled Trials as Topic; Research Design; Treatment Outcome; Venlafaxine Hydrochloride	2009
Perinatal depression: treatment options and dilemmas. Journal of psychiatry & neuroscience : JPN, 2008, Volume: 33, Issue:4 Topics: Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Case-Control Studies; Cyclohexanols; Depression, Postpartum; Depressive Disorder; Female; Fetal Diseases; Humans; Infant, Newborn; Lithium Carbonate; Perinatology; Pregnancy; Selective Serotonin Reuptake Inhibitors; Valproic Acid; Venlafaxine Hydrochloride	2008
Are SNRIs more effective than SSRIs? A review of the current state of the controversy. Psychopharmacology bulletin, 2008, Volume: 41, Issue:2 Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Depressive Disorder; Humans; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2008
[Mood disorders]. La Revue du praticien, 2008, Oct-31, Volume: 58, Issue:16 Topics: Adolescent; Adult; Age Factors; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Diagnosis, Differential; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Hospitalization; Humans; Male; Mood Disorders; Personality Disorders; Pregnancy; Prognosis; Psychotherapy; Psychotropic Drugs; Recurrence; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Suicide; Time Factors; Venlafaxine Hydrochloride; Young Adult	2008
Desvenlafaxine succinate: a newer antidepressant for the treatment of depression and somatic symptoms. Postgraduate medicine, 2010, Volume: 122, Issue:1 Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder; Desvenlafaxine Succinate; Humans; Neurotransmitter Uptake Inhibitors; Receptors, Adrenergic; Somatoform Disorders; Vasomotor System	2010
Interactions between tamoxifen and antidepressants via cytochrome P450 2D6. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:12 Topics: Antidepressive Agents; Bupropion; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 Enzyme System; Depressive Disorder; Drug Interactions; Female; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Venlafaxine Hydrochloride	2009
CYP 2D6 PM status and antidepressant response to nortriptyline and venlafaxine: is it more than just drug metabolism? Journal of clinical psychopharmacology, 2011, Volume: 31, Issue:2 Topics: Antidepressive Agents; Catalysis; Cyclohexanols; Cytochrome P-450 CYP2D6; Depressive Disorder; Humans; Nortriptyline; Substrate Specificity; Treatment Outcome; Venlafaxine Hydrochloride	2011
What can we learn from Chinese randomized controlled trials? A systematic review and meta-analysis of Chinese venlafaxine studies. Journal of clinical psychopharmacology, 2011, Volume: 31, Issue:2 Topics: Asian People; Cyclohexanols; Depressive Disorder; Humans; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride	2011
Combining antidepressants for treatment-resistant depression: a review. The Journal of clinical psychiatry, 2002, Volume: 63, Issue:8 Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Humans; Mianserin; Monoamine Oxidase Inhibitors; Morpholines; Psychiatric Status Rating Scales; Reboxetine; Research Design; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2002
Venlafaxine: a new class of antidepressant. Hospital medicine (London, England : 1998), 2002, Volume: 63, Issue:9 Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depressive Disorder; Humans; Venlafaxine Hydrochloride	2002
An overview of the clinical efficacy of mirtazapine. Human psychopharmacology, 2002, Volume: 17 Suppl 1 Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Humans; Mianserin; Mirtazapine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride	2002
[Pharmacological justification for the use of new antidepressant drugs]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2002, Volume: 13, Issue:75 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Humans; Mianserin; Mirtazapine; Piperazines; Triazoles; Venlafaxine Hydrochloride	2002
Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression. Biological psychiatry, 2002, Dec-15, Volume: 52, Issue:12 Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Paroxetine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride	2002
Achieving remission from depression with venlafaxine and venlafaxine extended release: a literature review of comparative studies with selective serotonin reuptake inhibitors. Acta psychiatrica Scandinavica. Supplementum, 2002, Issue:415 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Humans; Multicenter Studies as Topic; Placebos; Randomized Controlled Trials as Topic; Treatment Outcome; Venlafaxine Hydrochloride	2002
Depression in children and adolescents. American family physician, 2003, Feb-01, Volume: 67, Issue:3 Topics: Adolescent; Antidepressive Agents, Tricyclic; Child; Cognitive Behavioral Therapy; Cyclohexanols; Depressive Disorder; Electroconvulsive Therapy; Humans; Hypericum; Lithium; Monoamine Oxidase Inhibitors; Phytotherapy; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2003
New hope in the treatment of painful symptoms in depression. Current opinion in investigational drugs (London, England : 2000), 2003, Volume: 4, Issue:1 Topics: Animals; Antidepressive Agents; Clinical Trials as Topic; Cyclohexanols; Cyclopropanes; Depressive Disorder; Duloxetine Hydrochloride; Humans; Milnacipran; Pain; Thiophenes; Venlafaxine Hydrochloride	2003
Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of major depression: a comparison of venlafaxine, selective serotonin reuptake inhibitors, and placebo. The Journal of clinical psychiatry, 2003, Volume: 64, Issue:3 Topics: Algorithms; Ambulatory Care; Analysis of Variance; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Humans; Outcome Assessment, Health Care; Placebos; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Recurrence; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Terminology as Topic; Treatment Outcome; Venlafaxine Hydrochloride	2003
Physical symptoms of depression: unmet needs in special populations. The Journal of clinical psychiatry, 2003, Volume: 64 Suppl 7 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Age Factors; Antidepressive Agents; Child; Comorbidity; Cyclohexanols; Delivery of Health Care; Depressive Disorder; Diagnosis, Differential; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Pain; Poverty; Selective Serotonin Reuptake Inhibitors; Sex Factors; Thiophenes; Venlafaxine Hydrochloride	2003
Venlafaxine: a 2003 update. Clinical therapeutics, 2003, Volume: 25, Issue:8 Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2003
Antidepressant monotherapy for bipolar type II major depression. Bipolar disorders, 2003, Volume: 5, Issue:6 Topics: Adult; Affect; Antidepressive Agents, Second-Generation; Bipolar Disorder; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Female; Fluoxetine; Humans; Male; Practice Guidelines as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2003
Improving antidepressant adherence. The Journal of clinical psychiatry, 2003, Volume: 64 Suppl 18 Topics: Antidepressive Agents; Bupropion; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Health Promotion; Humans; Paroxetine; Patient Compliance; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride	2003
The treatment of depression with different formulations of venlafaxine: a comparative analysis. Human psychopharmacology, 2004, Volume: 19, Issue:1 Topics: Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Humans; Venlafaxine Hydrochloride	2004
Selective versus multi-transmitter antidepressants: are two mechanisms better than one? The Journal of clinical psychiatry, 2004, Volume: 65 Suppl 4 Topics: Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Humans; Patient Care Planning; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2004
Common pathways of depression and pain. The Journal of clinical psychiatry, 2004, Volume: 65 Suppl 12 Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Brain; Chronic Disease; Cyclohexanols; Depressive Disorder; Diabetic Neuropathies; Duloxetine Hydrochloride; Humans; Neurodegenerative Diseases; Neuronal Plasticity; Neurons; Norepinephrine; Pain; Recurrence; Selective Serotonin Reuptake Inhibitors; Serotonin; Thiophenes; Venlafaxine Hydrochloride	2004
Can monoamine-based therapies be improved? The Journal of clinical psychiatry, 2002, Volume: 63 Suppl 2 Topics: Adrenergic beta-Antagonists; Antidepressive Agents; Biogenic Monoamines; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Duloxetine Hydrochloride; Humans; Receptors, Biogenic Amine; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride	2002
Depression in children and adolescents. Clinical evidence, 2004, Issue:11 Topics: Adolescent; Antidepressive Agents, Tricyclic; Child; Cyclohexanols; Depressive Disorder; Humans; Monoamine Oxidase Inhibitors; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2004
Managing depressive and anxiety disorders with escitalopram. Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:4 Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Citalopram; Cyclohexanols; Depressive Disorder; Humans; Models, Economic; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Stereoisomerism; Venlafaxine Hydrochloride	2006
Depression in adults. Clinical evidence, 2006, Issue:15 Topics: Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder; Electroconvulsive Therapy; Humans; Hypericum; Monoamine Oxidase Inhibitors; Morpholines; Phytotherapy; Plant Preparations; Psychotherapy; Reboxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2006
[Applications and safety of modern antidepressants in patients with liver diseases]. Wiadomosci lekarskie (Warsaw, Poland : 1960), 2007, Volume: 60, Issue:1-2 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Cyclopropanes; Depressive Disorder; Humans; Liver Diseases; Mianserin; Milnacipran; Mirtazapine; Monoamine Oxidase Inhibitors; Piperazines; Risk Factors; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride	2007
Maintenance therapy to prevent recurrence of depression: summary and implications of the PREVENT study. Expert review of neurotherapeutics, 2008, Volume: 8, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Dizziness; Double-Blind Method; Female; Fluoxetine; Gastrointestinal Diseases; Headache; Humans; Hypertension; Male; Middle Aged; Respiratory Tract Infections; Secondary Prevention; Treatment Outcome; Venlafaxine Hydrochloride	2008
Nefazodone and venlafaxine: two new agents for the treatment of depression. The Journal of family practice, 1995, Volume: 41, Issue:6 Topics: Antidepressive Agents; Consumer Product Safety; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Family Practice; Humans; Norepinephrine; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride	1995
Safety and tolerance profile of venlafaxine. International clinical psychopharmacology, 1995, Volume: 10 Suppl 2 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Drug Tolerance; Humans; Venlafaxine Hydrochloride	1995
Rapid onset of action of venlafaxine. International clinical psychopharmacology, 1995, Volume: 10 Suppl 2 Topics: Antidepressive Agents, Second-Generation; Controlled Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Humans; Long-Term Care; Time Factors; Venlafaxine Hydrochloride	1995
Clinical utility of venlafaxine in comparison with other antidepressants. International clinical psychopharmacology, 1995, Volume: 10 Suppl 2 Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Venlafaxine Hydrochloride	1995
Pharmacologic profile and efficacy of venlafaxine. International clinical psychopharmacology, 1995, Volume: 10 Suppl 2 Topics: Animals; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Venlafaxine Hydrochloride	1995
Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine. The Journal of clinical psychiatry, 1995, Volume: 56 Suppl 6 Topics: 1-Naphthylamine; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Design; Drug Tolerance; Drugs, Investigational; Fluoxetine; Humans; Imipramine; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride	1995
Evolutionary trends in the pharmacotherapeutic management of depression. The Journal of clinical psychiatry, 1994, Volume: 55 Suppl Topics: Adolescent; Adult; Age Factors; Aged; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Child; Clinical Trials as Topic; Cyclohexanols; Decision Trees; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Humans; Piperazines; Placebos; Recurrence; Selective Serotonin Reuptake Inhibitors; Trazodone; Triazoles; Venlafaxine Hydrochloride	1994
The role of venlafaxine in rational antidepressant therapy. The Journal of clinical psychiatry, 1994, Volume: 55 Suppl A Topics: Age Factors; Aged; Ambulatory Care; Animals; Antidepressive Agents; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Female; Fluoxetine; Hospitalization; Humans; Male; Rats; Receptors, Neurotransmitter; Venlafaxine Hydrochloride	1994
Antidepressant drug selection: criteria and options. The Journal of clinical psychiatry, 1994, Volume: 55 Suppl A Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Design; Drug Interactions; Follow-Up Studies; Humans; Monoamine Oxidase Inhibitors; Venlafaxine Hydrochloride	1994
Geriatric depression: brain imaging correlates and pharmacologic considerations. The Journal of clinical psychiatry, 1994, Volume: 55 Suppl A Topics: Age Factors; Aged; Antidepressive Agents; Brain; Bupropion; Cerebrovascular Circulation; Cyclohexanols; Depressive Disorder; Humans; Intracranial Arteriosclerosis; Magnetic Resonance Imaging; Models, Neurological; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Tomography, X-Ray Computed; Venlafaxine Hydrochloride	1994
Depression in the medically ill: choosing an antidepressant. The Journal of clinical psychiatry, 1994, Volume: 55 Suppl A Topics: Antidepressive Agents; Cerebrovascular Disorders; Clinical Trials as Topic; Comorbidity; Cyclohexanols; Decision Making; Dementia; Depressive Disorder; Humans; Neoplasms; Parkinson Disease; Prevalence; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	1994
Cardiovascular safety in depressed patients: focus on venlafaxine. The Journal of clinical psychiatry, 1995, Volume: 56, Issue:12 Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; Blood Pressure; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Heart Conduction System; Humans; Hypertension; Hypotension, Orthostatic; Incidence; Placebos; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	1995
New approaches to the treatment of depression. The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 4 Topics: Antidepressive Agents, Second-Generation; Brain; Bupropion; Citalopram; Cyclohexanols; Depressive Disorder; Dopamine; Duloxetine Hydrochloride; Humans; Receptors, Dopamine; Receptors, GABA; Receptors, Neurotransmitter; Receptors, Serotonin; Serotonin; Thiophenes; Venlafaxine Hydrochloride	1996
The diagnosis and treatment of late-life depression. The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 5 Topics: Age Factors; Aged; Antidepressive Agents; Anxiety Disorders; Bupropion; Cyclohexanols; Depressive Disorder; Diagnosis, Differential; Electroconvulsive Therapy; Female; Humans; Lithium; Male; Monoamine Oxidase Inhibitors; Piperazines; Selective Serotonin Reuptake Inhibitors; Sex Factors; Trazodone; Triazoles; Venlafaxine Hydrochloride	1996
Antidepressant options: venlafaxine in perspective. Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:3 Suppl 2 Topics: Antidepressive Agents, Second-Generation; Brain; Cyclohexanols; Depressive Disorder; Humans; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Serotonin; Treatment Outcome; Venlafaxine Hydrochloride	1996
Clinical evaluation of venlafaxine. Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:3 Suppl 2 Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	1996
Drug-drug interactions involving antidepressants: focus on venlafaxine. Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:3 Suppl 2 Topics: Animals; Antidepressive Agents, Second-Generation; Cyclohexanols; Cytochrome P-450 Enzyme Inhibitors; Depressive Disorder; Drug Interactions; Humans; Isoenzymes; Liver; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	1996
Effectiveness of venlafaxine treatment in a broad spectrum of depressed patients: a meta-analysis. Psychopharmacology bulletin, 1995, Volume: 31, Issue:4 Topics: Adult; Age Factors; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride	1995
New antidepressant drugs and the treatment of depression in the medically ill patient. The Psychiatric clinics of North America, 1996, Volume: 19, Issue:3 Topics: Adjustment Disorders; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Depressive Disorder; Drug Interactions; Humans; Patient Care Team; Piperazines; Selective Serotonin Reuptake Inhibitors; Sick Role; Triazoles; Venlafaxine Hydrochloride	1996
Drug treatment of depression in the 1990s. An overview of achievements and future possibilities. Drugs, 1996, Volume: 52, Issue:5 Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Fluoxetine; Humans; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride	1996
Venlafaxine: a novel antidepressant that has a dual mechanism of action. Depression, 1996, Volume: 4, Issue:2 Topics: Animals; Antidepressive Agents, Second-Generation; Brain; Cyclohexanols; Depressive Disorder; Humans; Norepinephrine; Receptors, Adrenergic; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission; Treatment Outcome; Venlafaxine Hydrochloride	1996
Antidepressant discontinuation: a review of the literature. The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 7 Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Fluoxetine; Humans; Incidence; Monoamine Oxidase Inhibitors; Paroxetine; Recurrence; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Syndrome; Venlafaxine Hydrochloride	1997
Antidepressants. The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 6 Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Humans; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride	1997
Safety and tolerability of the new antidepressants. The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 6 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Headache; Humans; Mianserin; Mirtazapine; Nausea; Piperazines; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Triazoles; Venlafaxine Hydrochloride	1997
Development of new antidepressants. The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 6 Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depressive Disorder; Drug Approval; Humans; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Neurotransmitter Uptake Inhibitors; Receptors, Adrenergic; Receptors, Neurotransmitter; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	1997
Antidepressants in the treatment of premenstrual dysphoric disorder. The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 14 Topics: Adult; Antidepressive Agents; Clinical Trials as Topic; Clomipramine; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Female; Humans; Lithium; Luteal Phase; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Terminology as Topic; Treatment Outcome; Venlafaxine Hydrochloride	1997
A meta-analysis of the effects of venlafaxine on anxiety associated with depression. Journal of clinical psychopharmacology, 1998, Volume: 18, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride	1998
New antidepressants and the cytochrome P450 system: focus on venlafaxine, nefazodone, and mirtazapine. Depression and anxiety, 1998, Volume: 7 Suppl 1 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Depressive Disorder; Humans; Isoenzymes; Mianserin; Mirtazapine; Piperazines; Risk Factors; Triazoles; Venlafaxine Hydrochloride	1998
Pharmacokinetic interactions of antidepressants. The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 10 Topics: Antidepressive Agents; Cyclohexanols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Fluvoxamine; Humans; Mixed Function Oxygenases; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride	1998
Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients. The Journal of clinical psychiatry, 1998, Volume: 59, Issue:10 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Blood Pressure; Cyclohexanols; Depressive Disorder; Diastole; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Incidence; Male; Middle Aged; Posture; Proportional Hazards Models; Regression Analysis; Venlafaxine Hydrochloride	1998
Selecting an antidepressant by using mechanism of action to enhance efficacy and avoid side effects. The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 18 Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Bupropion; Cyclohexanols; Depressive Disorder; Drug Prescriptions; Humans; Monoamine Oxidase Inhibitors; Piperazines; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride	1998
Mechanism of action of antidepressant medications. The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 4 Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Down-Regulation; History, 20th Century; Humans; Monoamine Oxidase Inhibitors; Receptors, Adrenergic; Receptors, Adrenergic, beta; Receptors, Dopamine; Receptors, Glucocorticoid; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	1999
Antidepressant effectiveness in severe depression and melancholia. The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 4 Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Humans; Morpholines; Reboxetine; Research Design; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride	1999
Treatment of major depression: is improvement enough? The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 6 Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Fluoxetine; Humans; Psychiatric Status Rating Scales; Psychometrics; Risk Factors; Secondary Prevention; Treatment Outcome; Venlafaxine Hydrochloride	1999
The patient with comorbid depression and anxiety: the unmet need. The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 6 Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Clinical Trials as Topic; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Fluoxetine; Humans; Placebos; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride	1999
Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion. Journal of affective disorders, 1998, Volume: 51, Issue:3 Topics: Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Depressive Disorder; Humans; Piperazines; Triazoles; Venlafaxine Hydrochloride	1998
Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs. The Journal of clinical psychiatry, 1999, Volume: 60, Issue:5 Topics: Aged; Ambulatory Care; Antidepressive Agents; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Electroconvulsive Therapy; Hospitalization; Humans; Multicenter Studies as Topic; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride	1999
[Two new antidepressants: mirtazapine and venlafaxine]. Nederlands tijdschrift voor geneeskunde, 1999, May-01, Volume: 143, Issue:18 Topics: Adrenergic alpha-Antagonists; Benzamides; Cyclohexanols; Depressive Disorder; Drug Interactions; Female; Humans; Male; Mianserin; Mirtazapine; Moclobemide; Monoamine Oxidase Inhibitors; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride	1999
[Specifics of a dual action: toward new and more effective antidepressants?]. L'Encephale, 1999, Volume: 25 Spec No 2 Topics: Acetylcholine; Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Brain; Cyclohexanols; Depressive Disorder; Dopamine; Endocrine System; Enzymes; Homeostasis; Homovanillic Acid; Monoamine Oxidase; Norepinephrine; Serotonin; Venlafaxine Hydrochloride	1999
Mirtazapine: clinical overview. The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 17 Topics: Adrenergic alpha-Antagonists; Aged; Antidepressive Agents, Tricyclic; Clomipramine; Controlled Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Humans; Meta-Analysis as Topic; Mianserin; Middle Aged; Mirtazapine; Placebos; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	1999
Antidepressant treatment of the depressed patient with insomnia. The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 17 Topics: Antidepressive Agents, Tricyclic; Comorbidity; Cyclohexanols; Depressive Disorder; Fluoxetine; Humans; Mianserin; Mirtazapine; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sleep; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride	1999
Practical considerations for the treatment of depression in elderly and very elderly long-term care patients. The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 20 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Cyclohexanols; Depressive Disorder; Humans; Long-Term Care; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	1999
Pharmacokinetic considerations of antidepressant use in the elderly. The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 20 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Second-Generation; Biotransformation; Bupropion; Creatinine; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Female; Half-Life; Humans; Intestinal Absorption; Liver; Male; Middle Aged; Piperazines; Triazoles; Venlafaxine Hydrochloride	1999
Evolution of remission as the new standard in the treatment of depression. The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 22 Topics: Antidepressive Agents; Clinical Trials as Topic; Clomipramine; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Mianserin; Mirtazapine; Prevalence; Psychiatric Status Rating Scales; Recurrence; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride	1999
The functional anatomy, neurochemistry, and pharmacology of anxiety. The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 22 Topics: Adrenergic Uptake Inhibitors; Amygdala; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Clomipramine; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Humans; Norepinephrine; Prefrontal Cortex; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride	1999
Venlafaxine extended release (XR) in the treatment of generalized anxiety disorder. The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 22 Topics: Ambulatory Care; Antidepressive Agents, Second-Generation; Anxiety Disorders; Buspirone; Clinical Trials as Topic; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Humans; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride	1999
Overview of antidepressants currently used to treat anxiety disorders. The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 22 Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Humans; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	1999
SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression. Lancet (London, England), 2000, Mar-11, Volume: 355, Issue:9207 Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Mianserin; Mirtazapine; Morpholines; Piperazines; Reboxetine; Structure-Activity Relationship; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride	2000
[Venlafaxine withdrawal syndrome: report of six cases and review of the literature]. La Revue de medecine interne, 2000, Volume: 21, Issue:3 Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Fatigue; Female; Gastrointestinal Diseases; Hallucinations; Headache; Humans; Male; Middle Aged; Paresthesia; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Time Factors; Venlafaxine Hydrochloride	2000
Use of venlafaxine in children and adolescents: a review of current literature. Depression and anxiety, 2000, Volume: 12 Suppl 1 Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Autistic Disorder; Child; Conduct Disorder; Cyclohexanols; Depressive Disorder; Humans; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride	2000
Pharmacoeconomic studies of antidepressants: focus on venlafaxine. Depression and anxiety, 2000, Volume: 12 Suppl 1 Topics: Antidepressive Agents, Second-Generation; Buspirone; Clinical Trials as Topic; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder; Drug Tolerance; Fluoxetine; Fluvoxamine; Humans; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	2000
Venlafaxine XR in the treatment of anxiety. Acta psychiatrica Scandinavica. Supplementum, 2000, Issue:406 Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Humans; Treatment Outcome; Venlafaxine Hydrochloride	2000
Psychopharmacologic treatment of adolescent depression. Archives of psychiatric nursing, 2001, Volume: 15, Issue:1 Topics: Adolescent; Child; Cyclohexanols; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride	2001
Evidence of early onset of antidepressant effect in randomized controlled trials. The Journal of clinical psychiatry, 2001, Volume: 62 Suppl 4 Topics: Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Mianserin; Mirtazapine; Personality Inventory; Placebos; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride	2001
Possible neurobiological mechanisms underlying faster onset of antidepressant action. The Journal of clinical psychiatry, 2001, Volume: 62 Suppl 4 Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder; Humans; Mianserin; Mirtazapine; Norepinephrine; Receptors, Neurotransmitter; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride	2001
Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. The British journal of psychiatry : the journal of mental science, 2001, Volume: 178 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2001
Pharmacology of rapid-onset antidepressant treatment strategies. The Journal of clinical psychiatry, 2001, Volume: 62 Suppl 15 Topics: Antidepressive Agents, Tricyclic; Autoreceptors; Cyclohexanols; Depressive Disorder; Drug Synergism; Drug Therapy, Combination; Hippocampus; Humans; Mianserin; Mirtazapine; Norepinephrine; Pindolol; Pyramidal Cells; Raphe Nuclei; Receptor, Serotonin, 5-HT1B; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission; Treatment Outcome; Venlafaxine Hydrochloride	2001
Do some antidepressants work faster than others? The Journal of clinical psychiatry, 2001, Volume: 62 Suppl 15 Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Fluoxetine; Humans; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2001
Attaining remission in generalized anxiety disorder: venlafaxine extended release comparative data. The Journal of clinical psychiatry, 2001, Volume: 62 Suppl 19 Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Clinical Trials as Topic; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Drug Administration Schedule; Humans; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Remission Induction; Survival Analysis; Treatment Outcome; Venlafaxine Hydrochloride	2001
Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis. The British journal of psychiatry : the journal of mental science, 2002, Volume: 180 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2002
Generalized anxiety disorder in primary care: emerging issues in management and treatment. The Journal of clinical psychiatry, 2002, Volume: 63 Suppl 8 Topics: Adaptation, Psychological; Adolescent; Adult; Anxiety Disorders; Cognitive Behavioral Therapy; Comorbidity; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Physicians, Family; Prevalence; Primary Health Care; Recurrence; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; United States; Venlafaxine Hydrochloride	2002

Trials

104 trial(s) available for cyclohexanol and Depressive Disorder

Article	Year
Effects of antidepressant medication on emotion regulation in depressed patients: an iSPOT-D report. Journal of affective disorders, 2014, Volume: 159 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder; Emotions; Female; Humans; Male; Middle Aged; Repression, Psychology; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2014
Do withdrawal-like symptoms mediate increased marijuana smoking in individuals treated with venlafaxine-XR? Drug and alcohol dependence, 2014, Nov-01, Volume: 144 Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Marijuana Smoking; Middle Aged; Substance Withdrawal Syndrome; Treatment Outcome; Venlafaxine Hydrochloride	2014
Impairment and distress patterns distinguishing the melancholic depression subtype: an iSPOT-D report. Journal of affective disorders, 2015, Mar-15, Volume: 174 Topics: Adaptation, Psychological; Adolescent; Adult; Aged; Citalopram; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Risk Factors; Sertraline; Symptom Assessment; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2015
Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial. The American journal of psychiatry, 2015, Aug-01, Volume: 172, Issue:8 Topics: Adult; Antidepressive Agents; Anxiety; Citalopram; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Outpatients; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2015
Effects of fluoxetine and venlafaxine on serum brain derived neurotrophic factor levels in depressed patients. Progress in neuro-psychopharmacology & biological psychiatry, 2009, Mar-17, Volume: 33, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Biomarkers; Brain-Derived Neurotrophic Factor; Cyclohexanols; Depressive Disorder; Female; Fluoxetine; Humans; Male; Neurotransmitter Uptake Inhibitors; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sex Characteristics; Venlafaxine Hydrochloride	2009
Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response. Journal of the American Academy of Child and Adolescent Psychiatry, 2009, Volume: 48, Issue:3 Topics: Adolescent; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder; Drug Resistance; Female; Fluoxetine; Humans; Male; Paroxetine; Personality Inventory; Prognosis; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2009
The SNRI venlafaxine improves emotional unawareness in patients with post-stroke depression. Human psychopharmacology, 2009, Volume: 24, Issue:4 Topics: Aged; Cyclohexanols; Depressive Disorder; Emotions; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Self Concept; Stroke; Venlafaxine Hydrochloride	2009
Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine. Acta psychiatrica Scandinavica, 2010, Volume: 121, Issue:3 Topics: Adolescent; Adult; Affective Disorders, Psychotic; Aged; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Cyclohexanols; Depressive Disorder; Dibenzothiazepines; Double-Blind Method; Drug Administration Schedule; Drug Dosage Calculations; Drug Therapy, Combination; Female; Humans; Imipramine; Male; Middle Aged; Quetiapine Fumarate; Remission Induction; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2010
Association of FKBP5 polymorphisms with suicidal events in the Treatment of Resistant Depression in Adolescents (TORDIA) study. The American journal of psychiatry, 2010, Volume: 167, Issue:2 Topics: Adolescent; Cognitive Behavioral Therapy; Cyclohexanols; Depressive Disorder; Female; Genotype; Humans; Logistic Models; Male; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Selective Serotonin Reuptake Inhibitors; Suicide; Suicide, Attempted; Tacrolimus Binding Proteins; Treatment Failure; Venlafaxine Hydrochloride	2010
Changes in medial prefrontal cortex neural responses parallel successful antidepressant combination of venlafaxine and light therapy. Archives italiennes de biologie, 2009, Volume: 147, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Cognition; Combined Modality Therapy; Cyclohexanols; Depressive Disorder; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Phototherapy; Pilot Projects; Prefrontal Cortex; Venlafaxine Hydrochloride	2009
Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes. The American journal of psychiatry, 2010, Volume: 167, Issue:7 Topics: Adolescent; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder; Female; Fluoxetine; Humans; Male; Psychiatric Status Rating Scales; Remission Induction; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Failure; Venlafaxine Hydrochloride	2010
Duloxetine versus venlafaxine in the treatment of unipolar and bipolar depression. La Clinica terapeutica, 2010, Volume: 161, Issue:4 Topics: Adult; Antidepressive Agents; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Retrospective Studies; Thiophenes; Venlafaxine Hydrochloride	2010
Efficiency of venlafaxine in patients with psychogenic nonepileptic seizures and anxiety and/or depressive disorders. The Journal of neuropsychiatry and clinical neurosciences, 2010,Fall, Volume: 22, Issue:4 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depressive Disorder; Electroencephalography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Seizures; Statistics, Nonparametric; Venlafaxine Hydrochloride; Video Recording; Young Adult	2010
Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report. Journal of affective disorders, 2011, Volume: 133, Issue:3 Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Cyclohexanols; Depression; Depressive Disorder; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Outpatients; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride	2011
Suicide attempts and nonsuicidal self-injury in the treatment of resistant depression in adolescents: findings from the TORDIA study. Journal of the American Academy of Child and Adolescent Psychiatry, 2011, Volume: 50, Issue:8 Topics: Adolescent; Antidepressive Agents; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder; Drug Substitution; Female; Humans; Male; Proportional Hazards Models; Selective Serotonin Reuptake Inhibitors; Self Mutilation; Suicide Prevention; Venlafaxine Hydrochloride	2011
Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2012, Volume: 22, Issue:3 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Bupropion; Citalopram; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Suicide; Treatment Outcome; Venlafaxine Hydrochloride	2012
A short-term double-blind randomized controlled pilot trial with active or placebo pindolol in patients treated with venlafaxine for major depression. Nordic journal of psychiatry, 2012, Volume: 66, Issue:3 Topics: Adult; Aged; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pindolol; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride	2012
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. Neurology, 2012, Apr-17, Volume: 78, Issue:16 Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Parkinson Disease; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Venlafaxine Hydrochloride	2012
The superiority of antidepressant medication to cognitive behavior therapy in melancholic depressed patients: a 12-week single-blind randomized study. Acta psychiatrica Scandinavica, 2013, Volume: 128, Issue:4 Topics: Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Citalopram; Cognitive Behavioral Therapy; Cyclohexanols; Depressive Disorder; Desvenlafaxine Succinate; Female; Humans; Male; Middle Aged; Pilot Projects; Single-Blind Method; Treatment Outcome	2013
Social adjustment in depressed patients treated with venlafaxine and amitriptyline. International clinical psychopharmacology, 2002, Volume: 17, Issue:4 Topics: Adult; Aged; Amitriptyline; Analysis of Variance; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Venlafaxine Hydrochloride	2002
Venlafaxine compared with fluoxetine in outpatients with depression and concomitant anxiety. The international journal of neuropsychopharmacology, 2002, Volume: 5, Issue:2 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety Disorders; Belgium; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Outpatients; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride	2002
Two items on the Hamilton Depression rating scale are effective predictors of remission: comparison of selective serotonin reuptake inhibitors with the combined serotonin/norepinephrine reuptake inhibitor, venlafaxine. International clinical psychopharmacology, 2002, Volume: 17, Issue:6 Topics: Adolescent; Adult; Affect; Aged; Aged, 80 and over; Anxiety; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Placebos; Predictive Value of Tests; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride	2002
Safety and efficacy of high dose of venlafaxine XL in treatment resistant major depression. Human psychopharmacology, 2002, Volume: 17, Issue:7 Topics: Adult; Antidepressive Agents, Second-Generation; Blood Pressure; Body Weight; Cyclohexanols; Depressive Disorder; Drug Resistance; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Pulse; Social Behavior; Venlafaxine Hydrochloride	2002
Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of major depression: a comparison of venlafaxine, selective serotonin reuptake inhibitors, and placebo. The Journal of clinical psychiatry, 2003, Volume: 64, Issue:3 Topics: Algorithms; Ambulatory Care; Analysis of Variance; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Humans; Outcome Assessment, Health Care; Placebos; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Recurrence; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Terminology as Topic; Treatment Outcome; Venlafaxine Hydrochloride	2003
Probing the safety of medications in the frail elderly: evidence from a randomized clinical trial of sertraline and venlafaxine in depressed nursing home residents. The Journal of clinical psychiatry, 2003, Volume: 64, Issue:8 Topics: Aged; Aged, 80 and over; Cyclohexanols; Depressive Disorder; Female; Frail Elderly; Geriatric Assessment; Humans; Male; Middle Aged; Nursing Homes; Patient Dropouts; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	2003
A double-blind, randomised, placebo controlled study of venlafaxine XL in patients with generalised anxiety disorder in primary care. The British journal of general practice : the journal of the Royal College of General Practitioners, 2003, Volume: 53, Issue:495 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Primary Health Care; Quality of Life; Selective Serotonin Reuptake Inhibitors; United Kingdom; Venlafaxine Hydrochloride	2003
Lithium augmentation in venlafaxine non-responders: an open study. European psychiatry : the journal of the Association of European Psychiatrists, 2003, Volume: 18, Issue:6 Topics: Adult; Antidepressive Agents; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lithium Compounds; Male; Middle Aged; Personality Inventory; Sulfates; Treatment Outcome; Venlafaxine Hydrochloride	2003
Time course of clinical response to venlafaxine: relevance of plasma level and chirality. European journal of clinical pharmacology, 2004, Volume: 59, Issue:12 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Desvenlafaxine Succinate; Female; Humans; Male; Middle Aged; Severity of Illness Index; Stereoisomerism; Venlafaxine Hydrochloride	2004
A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder. Neuropsychobiology, 2004, Volume: 50, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Constipation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Primary Health Care; Psychiatric Status Rating Scales; Sweating; Treatment Outcome; Venlafaxine Hydrochloride	2004
Reboxetine adjunct for partial or nonresponders to antidepressant treatment. Journal of affective disorders, 2004, Volume: 81, Issue:1 Topics: Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Dysthymic Disorder; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Personality Inventory; Prospective Studies; Reboxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2004
A double-blind, randomized, 26-week study comparing the cognitive and psychomotor effects and efficacy of 75 mg (37.5 mg b.i.d.) venlafaxine and 75 mg (25 mg mane, 50 mg nocte) dothiepin in elderly patients with moderate major depression being treated in Journal of psychopharmacology (Oxford, England), 2004, Volume: 18, Issue:2 Topics: Aged; Cognition; Cyclohexanols; Depressive Disorder; Disorders of Excessive Somnolence; Dizziness; Dothiepin; Double-Blind Method; Drug Administration Schedule; Female; Flicker Fusion; Humans; Male; Narcolepsy; Nausea; Psychometrics; Psychomotor Performance; Time Factors; Venlafaxine Hydrochloride	2004
A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:9 Topics: Adolescent; Adult; Aged; Ambulatory Care; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Headache; Humans; Male; Middle Aged; Patient Dropouts; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride; Xerostomia	2004
Venlafaxine for the treatment of depressive episode during the course of schizophrenia. Journal of clinical psychopharmacology, 2004, Volume: 24, Issue:6 Topics: Adult; Aged; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Venlafaxine Hydrochloride	2004
Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification. Progress in neuro-psychopharmacology & biological psychiatry, 2005, Volume: 29, Issue:1 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety; Central Nervous System Depressants; Cyclohexanols; Depressive Disorder; Ethanol; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Patient Dropouts; Psychiatric Status Rating Scales; Socioeconomic Factors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2005
Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression. Biological psychiatry, 2005, Feb-01, Volume: 57, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Brain Mapping; Bupropion; Case-Control Studies; Cerebral Cortex; Cross-Over Studies; Cyclohexanols; Demography; Depressive Disorder; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Psychiatric Status Rating Scales; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride	2005
[Efficiency and safety of citalopram and venlafaxine in treatment of depressive disorders in elderly patients]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2004, Volume: 17, Issue:102 Topics: Aged; Citalopram; Cognition; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Neuropsychological Tests; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2004
Venlafaxine extended release versus conventional antidepressants in the remission of depressive disorders after previous antidepressant failure: ARGOS study. Depression and anxiety, 2005, Volume: 22, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Female; Humans; Male; Middle Aged; Odds Ratio; Remission Induction; Time Factors; Treatment Failure; Venlafaxine Hydrochloride	2005
Venlafaxine in the treatment of depressive and vasomotor symptoms in women with perimenopausal depression. Depression and anxiety, 2005, Volume: 22, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Female; Humans; Middle Aged; Perimenopause; Vasomotor System; Venlafaxine Hydrochloride	2005
Effects of paroxetine and venlafaxine XR on heart rate variability in depression. Journal of clinical psychopharmacology, 2005, Volume: 25, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Female; Heart Rate; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride	2005
[Trazodone and venlafaxine in treatment of depressive disorders]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2005, Volume: 18, Issue:107 Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Trazodone; Treatment Outcome; Venlafaxine Hydrochloride	2005
Antidepressant treatment outcomes of psychogenic movement disorder. The Journal of clinical psychiatry, 2005, Volume: 66, Issue:12 Topics: Adult; Ambulatory Care; Anxiety Disorders; Chronic Disease; Citalopram; Combined Modality Therapy; Comorbidity; Conversion Disorder; Cyclohexanols; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Hypochondriasis; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Somatoform Disorders; Treatment Outcome; Venlafaxine Hydrochloride	2005
Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. The British journal of psychiatry : the journal of mental science, 2006, Volume: 189 Topics: Adjuvants, Pharmaceutic; Adult; Affect; Antidepressive Agents; Antidepressive Agents, Second-Generation; Bipolar Disorder; Bupropion; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Risk Factors; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride	2006
CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine. Journal of clinical pharmacy and therapeutics, 2006, Volume: 31, Issue:5 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Cytochrome P-450 CYP2D6; Depressive Disorder; Desvenlafaxine Succinate; Female; Genotype; Humans; Male; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Venlafaxine Hydrochloride	2006
Early response to venlafaxine antidepressant correlates with lower ACTH levels prior to pharmacological treatment. Endocrine, 2006, Volume: 30, Issue:3 Topics: Adrenocorticotropic Hormone; Adult; Antidepressive Agents, Second-Generation; Circadian Rhythm; Cyclohexanols; Depressive Disorder; Female; Humans; Hydrocortisone; Male; Middle Aged; Pilot Projects; Treatment Outcome; Venlafaxine Hydrochloride	2006
Venlafaxine efficacy and tolerability in the treatment of post-stroke depression. Psychiatria Danubina, 2007, Volume: 19, Issue:1-2 Topics: Aged; Antidepressive Agents, Second-Generation; Cerebral Infarction; Cyclohexanols; Depressive Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Personality Assessment; Personality Inventory; Treatment Outcome; Venlafaxine Hydrochloride	2007
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:8 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Dizziness; Double-Blind Method; Female; Fluoxetine; Gastrointestinal Diseases; Headache; Humans; Hypertension; Male; Middle Aged; Respiratory Tract Infections; Secondary Prevention; Treatment Outcome; Venlafaxine Hydrochloride	2007
The cost-utility of maintenance treatment with venlafaxine in patients with recurrent major depressive disorder. International journal of clinical practice, 2008, Volume: 62, Issue:4 Topics: Antidepressive Agents, Second-Generation; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder; Double-Blind Method; Humans; Markov Chains; Quality-Adjusted Life Years; Recurrence; Risk Factors; Venlafaxine Hydrochloride	2008
Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study. Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:2 Topics: Administration, Oral; Adult; Aged; Antidepressive Agents, Second-Generation; Bipolar Disorder; Capsules; Cyclohexanols; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Lithium Carbonate; Lithium Compounds; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride	2008
Estimates of serotonin and norepinephrine transporter inhibition in depressed patients treated with paroxetine or venlafaxine. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2008, Volume: 33, Issue:13 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Brain; Brain Chemistry; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Nordefrin; Norepinephrine Plasma Membrane Transport Proteins; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Time Factors; Venlafaxine Hydrochloride; Young Adult	2008
Effectiveness of venlafaxine in patients hospitalized for major depression and melancholia. The Journal of clinical psychiatry, 1995, Volume: 56, Issue:10 Topics: Adult; Aged; Body Weight; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Hospitalization; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	1995
Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression. Journal of clinical psychopharmacology, 1994, Volume: 14, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Imipramine; Long-Term Care; Male; Venlafaxine Hydrochloride	1994
A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. The Venlafaxine French Inpatient Study Group. International clinical psychopharmacology, 1994, Volume: 9, Issue:3 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Hospitalization; Humans; Male; Middle Aged; Personality Inventory; Venlafaxine Hydrochloride	1994
Cumulative mean change procedure: application to a comparative trial of venlafaxine, imipramine, and placebo in the treatment of major depression. Progress in neuro-psychopharmacology & biological psychiatry, 1994, Volume: 18, Issue:4 Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Cyclohexanols; Data Interpretation, Statistical; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride	1994
Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients. The Journal of clinical psychiatry, 1994, Volume: 55, Issue:3 Topics: Acute Disease; Adult; Ambulatory Care; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride	1994
A comparison of venlafaxine, trazodone, and placebo in major depression. Journal of clinical psychopharmacology, 1994, Volume: 14, Issue:2 Topics: Adult; Antidepressive Agents; Blood Pressure; Cyclohexanols; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Female; Heart Rate; Humans; Male; Psychiatric Status Rating Scales; Single-Blind Method; Time Factors; Trazodone; Venlafaxine Hydrochloride	1994
Efficacy and safety of b.i.d. doses of venlafaxine in a dose-response study. Psychopharmacology bulletin, 1993, Volume: 29, Issue:2 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride	1993
Subchronic antidepressant treatment with venlafaxine or imipramine and effects on blood pressure and heart rate: assessment by automatic 24-hour monitoring. Pharmacopsychiatry, 1996, Volume: 29, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Heart Rate; Humans; Imipramine; Male; Middle Aged; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride	1996
Clinical evaluation of venlafaxine. Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:3 Suppl 2 Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	1996
Efficacy of venlafaxine and placebo during long-term treatment of depression: a pooled analysis of relapse rates. International clinical psychopharmacology, 1996, Volume: 11, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Recurrence; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride	1996
Relatively low doses of cisapride in the treatment of nausea in patients treated with venlafaxine for treatment-refractory depression. Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Cisapride; Cyclohexanols; Depressive Disorder; Drug Resistance; Female; Humans; Male; Middle Aged; Nausea; Piperidines; Psychiatric Status Rating Scales; Serotonin Antagonists; Venlafaxine Hydrochloride	1996
A double-blind comparison of venlafaxine and fluoxetine for treatment of major depression in outpatients. Progress in neuro-psychopharmacology & biological psychiatry, 1996, Volume: 20, Issue:1 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Venlafaxine Hydrochloride	1996
Venlafaxine or bupropion responders but not nonresponders show baseline prefrontal and paralimbic hypometabolism compared with controls. Psychopharmacology bulletin, 1996, Volume: 32, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cerebrovascular Circulation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Prefrontal Cortex; Tomography, Emission-Computed; Venlafaxine Hydrochloride	1996
A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression. Psychopharmacology bulletin, 1996, Volume: 32, Issue:4 Topics: Administration, Oral; Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Sleep; Venlafaxine Hydrochloride	1996
Curvaceous model of recovery from depression. Lancet (London, England), 1997, Feb-15, Volume: 349, Issue:9050 Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depressive Disorder; Humans; Models, Statistical; Piperazines; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride	1997
Venlafaxine in the treatment of children and adolescents with major depression. Psychopharmacology bulletin, 1997, Volume: 33, Issue:1 Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride	1997
A randomised, double-blind, parallel-group comparison of venlafaxine and dothiepin in geriatric patients with major depression. International journal of clinical practice, 1997, Volume: 51, Issue:4 Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Dothiepin; Double-Blind Method; Female; Humans; Male; Middle Aged; Treatment Outcome; Venlafaxine Hydrochloride	1997
Differential pharmacological treatment response in high angry hostile and low angry hostile depressed patients: a retrospective analysis. Journal of affective disorders, 1997, Volume: 45, Issue:3 Topics: 1-Naphthylamine; Adult; Ambulatory Care; Analysis of Variance; Anger; Cyclohexanols; Depressive Disorder; Desipramine; Female; Hostility; Humans; Male; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	1997
Once-daily venlafaxine extended release (XR) and venlafaxine immediate release (IR) in outpatients with major depression. Venlafaxine XR 208 Study Group. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 1997, Volume: 9, Issue:3 Topics: Adolescent; Adult; Aged; Analysis of Variance; Antidepressive Agents, Second-Generation; Chi-Square Distribution; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Longitudinal Studies; Male; Middle Aged; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride	1997
Efficacy and tolerability of once-daily venlafaxine extended release (XR) in outpatients with major depression. The Venlafaxine XR 209 Study Group. The Journal of clinical psychiatry, 1997, Volume: 58, Issue:9 Topics: Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Nausea; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Venlafaxine Hydrochloride	1997
Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine. The American journal of psychiatry, 1997, Volume: 154, Issue:12 Topics: Adult; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	1997
The use of venlafaxine in the treatment of major depression and major depression associated with anxiety: a dose-response study. Venlafaxine Investigator Study Group. Journal of clinical psychopharmacology, 1998, Volume: 18, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depressive Disorder; Dizziness; Double-Blind Method; Female; Humans; Male; Nausea; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	1998
Efficacy of once-daily venlafaxine extended release (XR) for symptoms of anxiety in depressed outpatients. Journal of affective disorders, 1998, Volume: 47, Issue:1-3 Topics: Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cohort Studies; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	1998
A benefit-risk analysis of once-daily venlafaxine extended release (XR) and venlafaxine immediate release (IR) in outpatients with major depression. Psychopharmacology bulletin, 1997, Volume: 33, Issue:4 Topics: Antidepressive Agents, Second-Generation; Cost-Benefit Analysis; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Dizziness; Humans; Nausea; Selective Serotonin Reuptake Inhibitors; Statistics as Topic; Venlafaxine Hydrochloride	1997
A randomized, placebo-controlled, dose-response trial of venlafaxine hydrochloride in the treatment of major depression. The Journal of clinical psychiatry, 1998, Volume: 59, Issue:3 Topics: Adult; Aged; Ambulatory Care; Anorexia; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nausea; Placebos; Psychiatric Status Rating Scales; Sleep Wake Disorders; Treatment Outcome; Venlafaxine Hydrochloride	1998
Long-term treatment of geropsychiatric depressed patients with venlafaxine. Journal of affective disorders, 1997, Volume: 46, Issue:3 Topics: Adrenergic Uptake Inhibitors; Age Factors; Aged; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Recurrence; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	1997
Once- versus twice-daily venlafaxine therapy in major depression: a randomized, double-blind study. The Journal of clinical psychiatry, 1998, Volume: 59, Issue:5 Topics: Adult; Ambulatory Care; Cyclohexanols; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Half-Life; Humans; Linear Models; Male; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride	1998
Randomized, double-blind comparison of venlafaxine and fluoxetine in outpatients with major depression. The Journal of clinical psychiatry, 1998, Volume: 59, Issue:7 Topics: Ambulatory Care; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Fluoxetine; Humans; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	1998
A large open-label study of venlafaxine in depressed outpatients by community-based physicians. The Journal of clinical psychiatry, 1998, Volume: 59, Issue:10 Topics: Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Community Medicine; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Dysthymic Disorder; Family Practice; Female; Humans; Male; Middle Aged; Nausea; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride; Xerostomia	1998
Venlafaxine but not bupropion decreases cerebrospinal fluid 5-hydroxyindoleacetic acid in unipolar depression. Biological psychiatry, 1999, Feb-01, Volume: 45, Issue:3 Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Brain; Bupropion; Cross-Over Studies; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Serotonin; Venlafaxine Hydrochloride	1999
Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group. The Journal of clinical psychiatry, 1999, Volume: 60, Issue:1 Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Anxiety Disorders; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Middle Aged; Placebos; Prospective Studies; Treatment Outcome; Venlafaxine Hydrochloride	1999
Pharmacoeconomic analysis of venlafaxine in the treatment of major depressive disorder. PharmacoEconomics, 1997, Volume: 12, Issue:2 Pt 2 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Models, Economic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	1997
The effects of venlafaxine on social activity level in depressed outpatients. The Journal of clinical psychiatry, 1999, Volume: 60, Issue:3 Topics: Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Interpersonal Relations; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	1999
Venlafaxine in treatment-resistant major depression: a Canadian multicenter, open-label trial. Journal of clinical psychopharmacology, 1999, Volume: 19, Issue:5 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Canada; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride	1999
Medical resource use and cost of venlafaxine or tricyclic antidepressant therapy. Following selective serotonin reuptake inhibitor therapy for depression. PharmacoEconomics, 1999, Volume: 15, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Costs and Cost Analysis; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Managed Care Programs; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	1999
Venlafaxine and paroxetine in treatment-resistant depression. Double-blind, randomised comparison. The British journal of psychiatry : the journal of mental science, 1999, Volume: 175 Topics: Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance; Female; Humans; Male; Middle Aged; Paroxetine; Treatment Outcome; Venlafaxine Hydrochloride	1999
Venlafaxine versus fluvoxamine in the treatment of delusional depression: a pilot double-blind controlled study. The Journal of clinical psychiatry, 2000, Volume: 61, Issue:1 Topics: Adult; Affective Disorders, Psychotic; Cyclohexanols; Delusions; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Fluvoxamine; Humans; Male; Middle Aged; Pilot Projects; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2000
A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression. Journal of affective disorders, 1999, Volume: 56, Issue:2-3 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Treatment Outcome; Venlafaxine Hydrochloride	1999
Venlafaxine versus fluoxetine in the treatment of atypical anorectic outpatients: a preliminary study. Eating and weight disorders : EWD, 1999, Volume: 4, Issue:1 Topics: Adolescent; Adult; Anorexia Nervosa; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Cyclohexanols; Depressive Disorder; Female; Fluoxetine; Humans; Personality Inventory; Venlafaxine Hydrochloride	1999
Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group. The Journal of clinical psychiatry, 2000, Volume: 61, Issue:2 Topics: Adult; Aged; Ambulatory Care; Cyclohexanols; Depressive Disorder; Diarrhea; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Headache; Humans; Male; Middle Aged; Nausea; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	2000
Seizure activity and safety in combined treatment with venlafaxine and ECT: a pilot study. The journal of ECT, 2000, Volume: 16, Issue:1 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Blood Pressure; Combined Modality Therapy; Cyclohexanols; Depressive Disorder; Electrocardiography; Electroconvulsive Therapy; Female; Humans; Male; Middle Aged; Seizures; Venlafaxine Hydrochloride	2000
Double-blind comparison of venlafaxine and amitriptyline in outpatients with major depression with or without melancholia. Journal of psychopharmacology (Oxford, England), 2000, Volume: 14, Issue:1 Topics: Adolescent; Adult; Ambulatory Care; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Personality Inventory; Treatment Outcome; Venlafaxine Hydrochloride	2000
Combined treatment with venlafaxine and tricyclic antidepressants in depressed patients who had partial response to clomipramine or imipramine: initial findings. The Journal of clinical psychiatry, 2000, Volume: 61, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clomipramine; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2000
Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder. The American journal of psychiatry, 2000, Volume: 157, Issue:6 Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Anxiety Disorders; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebos; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride	2000
Increased remission rates with venlafaxine compared with fluoxetine in hospitalized patients with major depression and melancholia. International clinical psychopharmacology, 2000, Volume: 15, Issue:1 Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Hospitalization; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Recurrence; Venlafaxine Hydrochloride	2000
The efficacy and tolerability of venlafaxine and paroxetine in outpatients with depressive disorder or dysthymia. International clinical psychopharmacology, 2000, Volume: 15, Issue:1 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride	2000
Efficacy of venlafaxine and predictors of response in a prospective open-label study of patients with treatment-resistant major depression. Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Comorbidity; Cyclohexanols; Depressive Disorder; Drug Resistance; Female; Humans; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride	2000
A randomized, double-blind, parallel-group comparison of venlafaxine and clomipramine in outpatients with major depression. Journal of psychopharmacology (Oxford, England), 1998, Volume: 12, Issue:3 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clomipramine; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride	1998
Lithium augmentation of venlafaxine: an open-label trial. Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:5 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antimanic Agents; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Lithium; Male; Middle Aged; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride	2000
Reboxetine plus citalopram for refractory depression not responding to venlafaxine: possible mechanisms. Psychopharmacology, 2001, Volume: 153, Issue:4 Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depressive Disorder; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Morpholines; Reboxetine; Venlafaxine Hydrochloride	2001
Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: preliminary findings. Archives of general psychiatry, 2001, Volume: 58, Issue:7 Topics: Adult; Antidepressive Agents, Second-Generation; Basal Ganglia; Brain; Cyclohexanols; Depressive Disorder; Female; Frontal Lobe; Gyrus Cinguli; Humans; Limbic System; Magnetic Resonance Imaging; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotherapy; Regional Blood Flow; Technetium Tc 99m Exametazime; Temporal Lobe; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Venlafaxine Hydrochloride	2001
Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features. Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:4 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride	2001
Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder. The Journal of clinical psychiatry, 2001, Volume: 62, Issue:7 Topics: Adult; Anxiety Disorders; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Placebos; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2001
Placebo-controlled trial of venlafaxine for the treatment of major depression. Journal of clinical psychopharmacology, 1991, Volume: 11, Issue:4 Topics: Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride	1991
Venlafaxine in depressed outpatients. Psychopharmacology bulletin, 1991, Volume: 27, Issue:2 Topics: Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Double-Blind Method; Humans; Middle Aged; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride	1991

Other Studies

218 other study(ies) available for cyclohexanol and Depressive Disorder

Article	Year
Different serum BDNF levels in depression: results from BDNF studies in FYR Macedonia and Bulgaria. Psychiatria Danubina, 2013, Volume: 25, Issue:2 Topics: Adult; Aged; Brain-Derived Neurotrophic Factor; Bulgaria; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Republic of North Macedonia; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2013
[Taperingstrips for paroxetine and venlafaxine]. Tijdschrift voor psychiatrie, 2013, Volume: 55, Issue:10 Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Feasibility Studies; Humans; Paroxetine; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2013
Cytochrome P450 2D6 poor metabolism, curvilinearity, and response: an intriguing observation requiring integration of psychopharmacology into pharmacogenetics. Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:6 Topics: Antidepressive Agents; Cyclohexanols; Cytochrome P-450 CYP2D6; Depressive Disorder; Humans; Nortriptyline	2013
Khedzela--a new brand of desvenlafaxine. The Medical letter on drugs and therapeutics, 2014, Jan-06, Volume: 56, Issue:1433 Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder; Desvenlafaxine Succinate; Humans; Neurotransmitter Uptake Inhibitors	2014
Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design. BMJ (Clinical research ed.), 2015, Apr-17, Volume: 350 Topics: Adult; Cohort Studies; Contraindications; Cyclohexanols; Depressive Disorder; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Logistic Models; Odds Ratio; Population Surveillance; Pregnancy; Pregnancy Complications; Scandinavian and Nordic Countries; Selective Serotonin Reuptake Inhibitors; Siblings; Venlafaxine Hydrochloride	2015
Safety of psychotropic drugs in pregnancy. BMJ (Clinical research ed.), 2015, May-13, Volume: 350 Topics: Antipsychotic Agents; Cyclohexanols; Depressive Disorder; Female; Heart Defects, Congenital; Humans; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors	2015
Clinically Useful Genetic Markers of Antidepressant Response: How Do We Get There From Here? The American journal of psychiatry, 2015, Aug-01, Volume: 172, Issue:8 Topics: Antidepressive Agents; Anxiety; Citalopram; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Sertraline	2015
[Optimization of the efficacy and safety of antidepressant therapy in patients of a geriatric psychiatric unit]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2015, Volume: 115, Issue:6 Topics: Acetamides; Acetylcarnitine; Aged; Antidepressive Agents; Apathy; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Male; Middle Aged; Treatment Outcome; Venlafaxine Hydrochloride	2015
SSRIs have a smaller benefit in paediatric when compared to adult major depressive disorder. Evidence-based mental health, 2016, Volume: 19, Issue:1 Topics: Adult; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Humans; Selective Serotonin Reuptake Inhibitors	2016
The influences of depression and venlafaxine use at therapeutic doses on atrial conduction. Journal of psychopharmacology (Oxford, England), 2009, Volume: 23, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Atrial Function; Cyclohexanols; Depressive Disorder; Electrocardiography; Female; Heart Atria; Heart Conduction System; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride	2009
High-dose venlafaxine in delusional and severely depressed patients. Journal of psychopharmacology (Oxford, England), 2009, Volume: 23, Issue:7 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Delusions; Depressive Disorder; Female; Humans; Male; Middle Aged; Treatment Outcome; Venlafaxine Hydrochloride	2009
Wine and drug evaluations: lessons on making comparisons of noninferiority. Journal of psychopharmacology (Oxford, England), 2008, Volume: 22, Issue:4 Topics: Anxiety Disorders; Cross-Cultural Comparison; Cyclohexanols; Depressive Disorder; Drug Approval; Duloxetine Hydrochloride; Europe; Humans; Placebo Effect; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome; United States; United States Food and Drug Administration; Venlafaxine Hydrochloride; Wine	2008
Venlafaxine dependence in a patient with a history of alcohol and amineptine misuse. Addiction (Abingdon, England), 2008, Volume: 103, Issue:9 Topics: Alcohol Deterrents; Alcoholism; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Dibenzocycloheptenes; Disulfiram; Humans; Male; Middle Aged; Prescription Drugs; Risk Factors; Substance-Related Disorders; Treatment Outcome; Venlafaxine Hydrochloride	2008
Recent NIMH clinical trials and implications for practice. Journal of the American Academy of Child and Adolescent Psychiatry, 2008, Volume: 47, Issue:12 Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Child, Preschool; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Fluoxetine; Humans; Mental Disorders; Methylphenidate; Multicenter Studies as Topic; National Institute of Mental Health (U.S.); Obsessive-Compulsive Disorder; Psychotropic Drugs; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States; Venlafaxine Hydrochloride	2008
Invivo antioxidant status: a putative target of antidepressant action. Progress in neuro-psychopharmacology & biological psychiatry, 2009, Mar-17, Volume: 33, Issue:2 Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antioxidants; Body Weight; Cyclohexanols; Depressive Disorder; Fluvoxamine; Food Preferences; Imipramine; Lipid Peroxidation; Protein Carbonylation; Rats; Restraint, Physical; Stress, Psychological; Swimming; Taste; Venlafaxine Hydrochloride	2009
Pharmacoeconomics of antidepressants in moderate-to-severe depressive disorder in Colombia. Revista panamericana de salud publica = Pan American journal of public health, 2008, Volume: 24, Issue:4 Topics: Amitriptyline; Antidepressive Agents; Colombia; Convulsive Therapy; Cost-Benefit Analysis; Cyclohexanols; Decision Trees; Depressive Disorder; Developing Countries; Drug Costs; Female; Fluoxetine; Health Expenditures; Hospitalization; Humans; Male; Models, Theoretical; Monte Carlo Method; National Health Programs; Office Visits; Psychotherapy; Venlafaxine Hydrochloride	2008
Case report: Effective treatment of Cotard's syndrome: quetiapine in combination with venlafaxine. Psychiatry and clinical neurosciences, 2009, Volume: 63, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Cyclohexanols; Depressive Disorder; Dibenzothiazepines; Drug Therapy, Combination; Female; Hallucinations; Humans; Psychiatric Status Rating Scales; Quetiapine Fumarate; Schizophrenia, Paranoid; Syndrome; Venlafaxine Hydrochloride	2009
Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. The American journal of psychiatry, 2009, Volume: 166, Issue:5 Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Body Mass Index; Case-Control Studies; Cyclohexanols; Depressive Disorder; Diabetes Mellitus; Female; Fluvoxamine; Humans; Incidence; Male; Middle Aged; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Time Factors; United Kingdom; Venlafaxine Hydrochloride	2009
Teenaged, depressed, and treatment resistant: what predicts self-harm? The American journal of psychiatry, 2009, Volume: 166, Issue:4 Topics: Adolescent; Antidepressive Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder; Drug Resistance; Humans; Risk Assessment; Risk Factors; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Suicide, Attempted; Venlafaxine Hydrochloride	2009
Antidepressant switching among adherent patients treated for depression. Psychiatric services (Washington, D.C.), 2009, Volume: 60, Issue:5 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Drug Administration Schedule; Humans; Mianserin; Middle Aged; Mirtazapine; Patient Compliance; Sertraline; Trazodone; Venlafaxine Hydrochloride; Young Adult	2009
Economic evaluation of duloxetine versus serotonin selective reuptake inhibitors and venlafaxine XR in treating major depressive disorder in Scotland. Journal of affective disorders, 2010, Volume: 120, Issue:1-3 Topics: Cost-Benefit Analysis; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Duloxetine Hydrochloride; Health Care Costs; Humans; Mianserin; Mirtazapine; Prevalence; Quality of Life; Recurrence; Remission Induction; Scotland; Selective Serotonin Reuptake Inhibitors; Thiophenes; Time Factors; Venlafaxine Hydrochloride	2010
TORDIA: unique opportunity to explore half-life theory. The American journal of psychiatry, 2009, Volume: 166, Issue:8 Topics: Adolescent; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Drug Resistance; Half-Life; Humans; Paroxetine; Randomized Controlled Trials as Topic; Risk Factors; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Suicide; Venlafaxine Hydrochloride	2009
Venlafaxine versus SSRI therapy for major depression. Results of comparative efficacy trials. Postgraduate medicine, 1999, Volume: 106, Issue:6 Suppl Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	1999
[Psycho- and pharmacotherapy of depressions. So you combine correctly]. MMW Fortschritte der Medizin, 2009, May-07, Volume: 151, Issue:19 Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Behavior Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder; Dopamine Uptake Inhibitors; Duloxetine Hydrochloride; Humans; Mianserin; Middle Aged; Mirtazapine; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride	2009
Desvenlafaxine: application withdrawal. Desvenlafaxine: withdrawal of marketing application for depression also. Prescrire international, 2009, Volume: 18, Issue:103 Topics: Antidepressive Agents; Cyclohexanols; Depression; Depressive Disorder; Desvenlafaxine Succinate; Europe; Hot Flashes; Humans; Investigational New Drug Application; Marketing of Health Services; Neurotransmitter Uptake Inhibitors; Postmenopause; United States	2009
[Therapeutic effects of venlafaxine extended release for patients with depressive and anxiety disorders in the German outpatient setting - results of 2 observational studies including 8500 patients]. Fortschritte der Neurologie-Psychiatrie, 2009, Volume: 77, Issue:11 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Female; Germany; Humans; Male; Middle Aged; Outpatients; Prospective Studies; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride	2009
Venlafaxine involves nitric oxide modulatory mechanism in experimental model of chronic behavior despair in mice. Brain research, 2010, Jan-22, Volume: 1311 Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety; Arginine; Caffeine; Central Nervous System Stimulants; Chronic Disease; Cyclohexanols; Depressive Disorder; Disease Models, Animal; Enzyme Inhibitors; Male; Methylene Blue; Mice; Mice, Inbred Strains; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Random Allocation; Swimming; Venlafaxine Hydrochloride	2010
Agomelatine: new drug. Adverse effects and no proven efficacy. Prescrire international, 2009, Volume: 18, Issue:104 Topics: Acetamides; Animals; Antidepressive Agents; Bias; Carcinogens; Clinical Trials as Topic; Cyclohexanols; Depression; Depressive Disorder; Double-Blind Method; Drug Approval; Europe; Fluoxetine; Humans; Hypnotics and Sedatives; Melatonin; Paroxetine; Psychiatric Status Rating Scales; Receptors, Melatonin; Recurrence; Selective Serotonin Reuptake Inhibitors; Suicide; Treatment Outcome; Venlafaxine Hydrochloride	2009
[Discontinuation of antidepressant serotonergic antidepressant]. Ugeskrift for laeger, 2010, Jan-25, Volume: 172, Issue:4 Topics: Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depressive Disorder; Diagnosis, Differential; Female; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2010
Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: a nested case-control study. BMJ (Clinical research ed.), 2010, Feb-05, Volume: 340 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Second-Generation; Case-Control Studies; Cyclohexanols; Death, Sudden, Cardiac; Depressive Disorder; Humans; Middle Aged; Odds Ratio; Risk Factors; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Young Adult	2010
Venlafaxine and cardiovascular toxicity. BMJ (Clinical research ed.), 2010, Feb-05, Volume: 340 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Death, Sudden, Cardiac; Depressive Disorder; Drug Overdose; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2010
Does night-time cortisol excretion normalize in the long-term course of depression? Pharmacopsychiatry, 2010, Volume: 43, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Circadian Rhythm; Cyclohexanols; Depressive Disorder; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Mianserin; Middle Aged; Mirtazapine; Pituitary-Adrenal System; Time Factors; Venlafaxine Hydrochloride	2010
[Depressive symptoms in a case of "posterior cortical atrophy"]. Fortschritte der Neurologie-Psychiatrie, 2010, Volume: 78, Issue:4 Topics: Affect; Antidepressive Agents, Second-Generation; Atrophy; Brain Diseases; Cerebral Cortex; Cognition Disorders; Cyclohexanols; Depressive Disorder; Electroencephalography; Evoked Potentials; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurodegenerative Diseases; Positron-Emission Tomography; Venlafaxine Hydrochloride	2010
Physician speciality and pain reduction in patients with depressive symptoms under treatment with venlafaxine. European psychiatry : the journal of the Association of European Psychiatrists, 2010, Volume: 25, Issue:8 Topics: Adult; Aged; Analgesics; Analysis of Variance; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Depressive Disorder; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Pain Perception; Physicians; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride	2010
Use of antidepressants during pregnancy and the risk of spontaneous abortion. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2010, Jul-13, Volume: 182, Issue:10 Topics: Abortion, Spontaneous; Adolescent; Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Case-Control Studies; Confidence Intervals; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Gestational Age; Humans; Middle Aged; Odds Ratio; Paroxetine; Pregnancy; Pregnancy Complications; Quebec; Registries; Risk Factors; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Young Adult	2010
Electroconvulsive therapy for lycanthropy and Cotard syndrome: a case report. The journal of ECT, 2010, Volume: 26, Issue:4 Topics: Adult; Anesthesia; Animals; Antidepressive Agents, Second-Generation; Cyclohexanols; Delusions; Depressive Disorder; Electroconvulsive Therapy; Electroencephalography; Female; Humans; Swine; Venlafaxine Hydrochloride	2010
An audit to compare discharge rates between antidepressant monotherapies prescribed for pure unipolar depression versus depression in the presence of other indications. Psychiatria Danubina, 2010, Volume: 22, Issue:2 Topics: Adult; Antidepressive Agents; Citalopram; Community Mental Health Centers; Comorbidity; Cyclohexanols; Depressive Disorder; England; Fluoxetine; Guideline Adherence; Humans; Medical Audit; Mianserin; Mirtazapine; Patient Discharge; Practice Patterns, Physicians'; Sertraline; Suicide; Suicide Prevention; Treatment Outcome; Venlafaxine Hydrochloride	2010
An audit to compare discharge rates and suicidality between antidepressant monotherapies prescribed for unipolar depression. Psychiatria Danubina, 2010, Volume: 22, Issue:2 Topics: Adult; Antidepressive Agents; Citalopram; Community Mental Health Centers; Cyclohexanols; Depressive Disorder; England; Humans; Medical Audit; Mianserin; Mirtazapine; Patient Discharge; Sertraline; Suicide; Suicide Prevention; Treatment Outcome; Venlafaxine Hydrochloride	2010
Suicide risk and choice of antidepressant. Psychiatria Danubina, 2010, Volume: 22, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Citalopram; Community Mental Health Centers; Cyclohexanols; Depressive Disorder; England; Female; Humans; Male; Practice Patterns, Physicians'; Risk Assessment; Secondary Prevention; Sex Factors; Suicide; Suicide Prevention; Suicide, Attempted; Venlafaxine Hydrochloride	2010
Chronic effects of venlafaxine on synaptophysin and neuronal cell adhesion molecule in the hippocampus of cerebral ischemic mice. Biochemistry and cell biology = Biochimie et biologie cellulaire, 2010, Volume: 88, Issue:4 Topics: Animals; Antidepressive Agents, Second-Generation; Brain Ischemia; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Hippocampus; Male; Mice; Neural Cell Adhesion Molecule L1; Neuronal Plasticity; Selective Serotonin Reuptake Inhibitors; Synaptophysin; Time Factors; Venlafaxine Hydrochloride	2010
Assessment of infant dose through milk in a lactating woman taking amisulpride and desvenlafaxine for treatment-resistant depression. Therapeutic drug monitoring, 2010, Volume: 32, Issue:6 Topics: Adult; Amisulpride; Antidepressive Agents; Breast Feeding; Cyclohexanols; Depressive Disorder; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Lactation; Milk, Human; Sulpiride	2010
Was Cipriani right? Audits to compare discharge rates and suicidality between antidepressant monotherapies used in a British community mental health team. Psychiatria Danubina, 2010, Volume: 22 Suppl 1 Topics: Antidepressive Agents; Citalopram; Community Mental Health Services; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Humans; Medical Audit; Mianserin; Mirtazapine; Outcome Assessment, Health Care; Patient Discharge; Sertraline; Suicidal Ideation; Suicide; Suicide Prevention; Treatment Outcome; United Kingdom; Venlafaxine Hydrochloride	2010
Venlafaxine plus mirtazapine as first-line treatment for melancholia: preliminary results. Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:12 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Humans; Mianserin; Mirtazapine; Severity of Illness Index; Venlafaxine Hydrochloride	2010
[Patch testing increases the likelihood of recognizing lamotrigine as a cause of drug-induced rash]. Actas dermo-sifiliograficas, 2011, Volume: 102, Issue:1 Topics: Antidepressive Agents; Antimanic Agents; Cyclohexanols; Depressive Disorder; Drug Eruptions; Drug Therapy, Combination; Female; Humans; Lamotrigine; Middle Aged; Patch Tests; Triazines; Venlafaxine Hydrochloride	2011
[Acute lethal poisoning with venlafaxine]. Przeglad lekarski, 2010, Volume: 67, Issue:8 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Drug Overdose; Fatal Outcome; Female; Humans; Middle Aged; Suicide; Venlafaxine Hydrochloride	2010
IFN-gamma reduction by tricyclic antidepressants. International journal of psychiatry in medicine, 2010, Volume: 40, Issue:4 Topics: Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Cytokines; Depressive Disorder; Desipramine; Desvenlafaxine Succinate; Female; Humans; Imipramine; In Vitro Techniques; Interferon-gamma; Male; Nortriptyline; Venlafaxine Hydrochloride	2010
Clinical and genetic correlates of suicidal ideation during antidepressant treatment in a depressed outpatient sample. Pharmacogenomics, 2011, Volume: 12, Issue:3 Topics: Adolescent; Adult; Aged; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clomipramine; Cyclohexanols; Depressive Disorder; Female; Genetic Association Studies; Humans; Male; Middle Aged; Paroxetine; Piperazines; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT1B; Severity of Illness Index; Suicidal Ideation; Tacrolimus Binding Proteins; Triazoles; Venlafaxine Hydrochloride; Young Adult	2011
Venlafaxine in somatopsychic and autopsychic depersonalization. Progress in neuro-psychopharmacology & biological psychiatry, 2011, Dec-01, Volume: 35, Issue:8 Topics: Agoraphobia; Cyclohexanols; Depersonalization; Depressive Disorder; Humans; Male; Obsessive Behavior; Panic Disorder; Paroxetine; Retreatment; Selective Serotonin Reuptake Inhibitors; Trimipramine; Venlafaxine Hydrochloride; Young Adult	2011
Does the presence of accompanying symptom clusters differentiate the comparative effectiveness of second-line medication strategies for treating depression? Depression and anxiety, 2011, Volume: 28, Issue:11 Topics: Adult; Bias; Bupropion; Buspirone; Cluster Analysis; Cyclohexanols; Depressive Disorder; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sertraline; Treatment Failure; Treatment Outcome; Venlafaxine Hydrochloride	2011
Early syphilitic meningoencephalitis masquerading as postclimacteric endogenous depression--a unique dermatologic presentation. Akusherstvo i ginekologiia, 2011, Volume: 50, Issue:2 Topics: Anti-Bacterial Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Female; Humans; Meningoencephalitis; Middle Aged; Penicillin G; Postmenopause; Skin; Syphilis; Venlafaxine Hydrochloride	2011
[Serotonin syndrome in the course of drug-poisoning--case presentation]. Przeglad lekarski, 2011, Volume: 68, Issue:8 Topics: Alcoholic Intoxication; Alkaloids; Azocines; Bradycardia; Cyclohexanols; Depressive Disorder; Electrocardiography; Female; Humans; Mianserin; Middle Aged; Moclobemide; Myoclonus; Quinolizines; Respiratory Insufficiency; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Suicide, Attempted; Venlafaxine Hydrochloride	2011
Time to discontinuation among the three second-generation antidepressants in a naturalistic outpatient setting of depression. Psychiatry and clinical neurosciences, 2011, Volume: 65, Issue:7 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Female; Humans; Korea; Male; Medication Adherence; Mianserin; Middle Aged; Mirtazapine; Outpatients; Paroxetine; Retrospective Studies; Venlafaxine Hydrochloride	2011
Treatment with duloxetine in adults and the incidence of cardiovascular events. Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:1 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cardiovascular Diseases; Case-Control Studies; Cause of Death; Cohort Studies; Cross-Sectional Studies; Cyclohexanols; Depressive Disorder; Duloxetine Hydrochloride; Electrocardiography; Female; Follow-Up Studies; Humans; Insurance Claim Review; Male; Propensity Score; Risk Factors; Selective Serotonin Reuptake Inhibitors; Thiophenes; United States; Venlafaxine Hydrochloride; Young Adult	2012
High venlafaxine serum levels after prior fluoxetine medication. Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:2 Topics: Antidepressive Agents, Second-Generation; Cholinergic Antagonists; Cyclohexanols; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder; Female; Fluoxetine; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline	2012
A case of primary progressive aphasia associated with depression. International journal of geriatric psychiatry, 2012, Volume: 27, Issue:4 Topics: Animal Assisted Therapy; Aphasia, Primary Progressive; Cyclohexanols; Depressive Disorder; Exercise Therapy; Female; Humans; Middle Aged; Psychotherapy, Group; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2012
Does aripiprazole protect from serotonin syndrome? Psychiatria Danubina, 2012, Volume: 24, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Borderline Personality Disorder; Cyclohexanols; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Tremor; Venlafaxine Hydrochloride; Young Adult	2012
Glad about SAD (PD). Neurology, 2012, Apr-17, Volume: 78, Issue:16 Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Parkinson Disease; Paroxetine; Venlafaxine Hydrochloride	2012
[A case of venlafaxine-induced syndrome of inappropriate ADH secretion (SIADH) - treatment with tolvaptan]. Deutsche medizinische Wochenschrift (1946), 2012, Volume: 137, Issue:21 Topics: Aged; Antidepressive Agents, Second-Generation; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cyclohexanols; Depressive Disorder; Diagnosis, Differential; Epilepsy, Generalized; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Tolvaptan; Venlafaxine Hydrochloride	2012
Chronic social defeat stress model: behavioral features, antidepressant action, and interaction with biological risk factors. Psychopharmacology, 2012, Volume: 224, Issue:2 Topics: Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Cyclohexanols; Depression; Depressive Disorder; Disease Models, Animal; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Risk Factors; RNA, Messenger; Social Behavior; Stress, Psychological; Thiazepines; Venlafaxine Hydrochloride; Vesicular Glutamate Transport Protein 1	2012
Platelet count alterations associated with escitalopram, venlafaxine and bupropion in depressive patients. Psychiatry and clinical neurosciences, 2012, Volume: 66, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Blood Platelets; Bupropion; Citalopram; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Platelet Count; Retrospective Studies; Venlafaxine Hydrochloride	2012
Prenatal exposure to antidepressants: how safe are they? The American journal of psychiatry, 2012, Volume: 169, Issue:11 Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Child Behavior Disorders; Cyclohexanols; Depressive Disorder; Female; Humans; Intelligence; Male; Neonatal Abstinence Syndrome; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2012
Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. The American journal of psychiatry, 2012, Volume: 169, Issue:11 Topics: Abnormalities, Drug-Induced; Adult; Antidepressive Agents, Second-Generation; Case-Control Studies; Child Behavior Disorders; Child, Preschool; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Infant; Infant, Newborn; Intelligence; Longitudinal Studies; Male; Neonatal Abstinence Syndrome; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Prospective Studies; Reference Values; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sex Factors; Venlafaxine Hydrochloride; Wechsler Scales	2012
Economic evaluation of St. John's wort (Hypericum perforatum) for the treatment of mild to moderate depression. Journal of affective disorders, 2013, Volume: 148, Issue:2-3 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Australia; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Humans; Hypericum; Markov Chains; Middle Aged; Models, Economic; Phytotherapy; Plant Preparations; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2013
Venlafaxine in a patient with idiopathic leukopenia and mirtazapine-induced severe neutropenia. The Journal of clinical psychiatry, 2002, Volume: 63, Issue:9 Topics: Agranulocytosis; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Comorbidity; Cyclohexanols; Depressive Disorder; Drug Hypersensitivity; Female; Humans; Leukopenia; Mianserin; Middle Aged; Mirtazapine; Neutropenia; Venlafaxine Hydrochloride	2002
Women with PTSD: the psychodynamic aspects of psychopharmacologic and "hands-on" psychiatric management. The Journal of the American Academy of Psychoanalysis, 2002,Fall, Volume: 30, Issue:3 Topics: Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Carbamazepine; Combined Modality Therapy; Cyclohexanols; Depressive Disorder; Female; Humans; Oxcarbazepine; Psychotropic Drugs; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride	2002
Hypokalemia with venlafaxine. The Journal of clinical psychiatry, 2002, Volume: 63, Issue:11 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Electrolytes; Humans; Hypokalemia; Hyponatremia; Inappropriate ADH Syndrome; Magnesium Deficiency; Male; Middle Aged; Venlafaxine Hydrochloride	2002
Serotonin syndrome induced by low-dose venlafaxine. The Annals of pharmacotherapy, 2003, Volume: 37, Issue:2 Topics: Adult; Cyclohexanols; Depressive Disorder; Female; Humans; Serotonin Syndrome; Venlafaxine Hydrochloride	2003
Changes in regional cerebral blood flow with venlafaxine in the treatment of major depression. The American journal of psychiatry, 2003, Volume: 160, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Brain; Cerebral Cortex; Cyclohexanols; Depressive Disorder; Female; Humans; Limbic System; Male; Middle Aged; Psychiatric Status Rating Scales; Regional Blood Flow; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Venlafaxine Hydrochloride	2003
Venlafaxine-induced delirium. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2003, Volume: 48, Issue:2 Topics: Cyclohexanols; Delirium; Depressive Disorder; Female; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2003
Erotomania induced by venlafaxine: a case study. Acta psychiatrica Scandinavica, 2003, Volume: 107, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Delusions; Depressive Disorder; Female; Humans; Love; Venlafaxine Hydrochloride	2003
Effects of 5-HT(6) receptor blockade on the neurochemical outcome of antidepressant treatment in the frontal cortex of the rat. Journal of neural transmission (Vienna, Austria : 1996), 2003, Volume: 110, Issue:6 Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Desipramine; Drug Synergism; Extracellular Space; Fluoxetine; Glutamic Acid; Male; Microdialysis; Neurons; Norepinephrine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Sulfonamides; Synaptic Transmission; Thiophenes; Venlafaxine Hydrochloride	2003
Randomized controlled trials in psychiatry. Part 1: methodology and critical evaluation. The Australian and New Zealand journal of psychiatry, 2003, Volume: 37, Issue:3 Topics: Cyclohexanols; Depressive Disorder; Double-Blind Method; Humans; Patient Selection; Psychiatry; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2003
A case report of paranoid delusion with venlafaxine use. Journal of the American Geriatrics Society, 2003, Volume: 51, Issue:7 Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Delusions; Depressive Disorder; Humans; Male; Paranoid Disorders; Venlafaxine Hydrochloride	2003
Selective serotonin reuptake inhibitors combined with venlafaxine in depressed patients who had partial response to venlafaxine: four cases. Progress in neuro-psychopharmacology & biological psychiatry, 2003, Volume: 27, Issue:5 Topics: Adult; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2003
Dosage finding and outcome of venlafaxine treatment in psychiatric outpatients and inpatients: results of a drug utilization observation study. Pharmacopsychiatry, 2003, Volume: 36, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Drug Utilization; Female; Hospitalization; Humans; Male; Middle Aged; Observation; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Venlafaxine Hydrochloride	2003
ECT resistance and early relapse: two cases of subsequent response to venlafaxine. The journal of ECT, 2003, Volume: 19, Issue:4 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Drug Resistance; Electroconvulsive Therapy; Female; Humans; Middle Aged; Patient Care Planning; Recurrence; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride	2003
Acute and continuation treatment adequacy with venlafaxine extended release compared with fluoxetine. Pharmacotherapy, 2004, Volume: 24, Issue:1 Topics: California; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Drug Administration Schedule; Female; Fluoxetine; Follow-Up Studies; Humans; Middle Aged; Retrospective Studies; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride	2004
Upregulation of CB1 receptors and agonist-stimulated [35S]GTPgammaS binding in the prefrontal cortex of depressed suicide victims. Molecular psychiatry, 2004, Volume: 9, Issue:2 Topics: Adolescent; Adult; Aged; Analgesics; Cyclohexanols; Depressive Disorder; Female; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Male; Middle Aged; Prefrontal Cortex; Receptor, Cannabinoid, CB1; Suicide; Sulfur Radioisotopes; Tritium; Up-Regulation	2004
Serotonin syndrome resulting from coadministration of tramadol, venlafaxine, and mirtazapine. The Annals of pharmacotherapy, 2004, Volume: 38, Issue:3 Topics: Analgesics, Opioid; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Pain; Polypharmacy; Serotonin Syndrome; Tramadol; Venlafaxine Hydrochloride	2004
Stimulatory effect of antidepressants on the production of IL-6. International immunopharmacology, 2004, Volume: 4, Issue:2 Topics: 5-Hydroxytryptophan; Adult; Age Factors; Aging; Antidepressive Agents; Blood Cells; Cyclohexanols; Depressive Disorder; Drug Combinations; Female; Fluoxetine; Humans; Imipramine; In Vitro Techniques; Inflammation; Interleukin-6; Male; Middle Aged; Tumor Necrosis Factor-alpha; Venlafaxine Hydrochloride	2004
Update: A 75-year-old man with depression. JAMA, 2004, Mar-10, Volume: 291, Issue:10 Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Male; Quality of Life; Venlafaxine Hydrochloride	2004
Any value in venlafaxine study? The British journal of general practice : the journal of the Royal College of General Practitioners, 2004, Volume: 54, Issue:499 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Publication Bias; Venlafaxine Hydrochloride	2004
Suicidal ideas with paroxetine or venlafaxine. Prescrire international, 2004, Volume: 13, Issue:69 Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Cyclohexanols; Depressive Disorder; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Suicide; Suicide, Attempted; United States	2004
Venlafaxine and SSRI remission data revisited. The British journal of psychiatry : the journal of mental science, 2004, Volume: 184 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Meta-Analysis as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2004
Venlafaxine and sour date nut. The American journal of psychiatry, 2004, Volume: 161, Issue:6 Topics: Adult; Anaphylaxis; Cyclohexanols; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Phytotherapy; Serotonin Syndrome; Venlafaxine Hydrochloride; Ziziphus	2004
Tolerability of high-dose venlafaxine in depressed patients. Journal of psychopharmacology (Oxford, England), 2004, Volume: 18, Issue:2 Topics: Adult; Aged; Blood Pressure; Cyclohexanols; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Formularies as Topic; Humans; Hypertension; Male; Middle Aged; Product Surveillance, Postmarketing; United Kingdom; Venlafaxine Hydrochloride	2004
Venlafaxine-induced increase in urinary frequency in 3 women. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:6 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Female; Humans; Polyuria; Urinary Incontinence; Urination Disorders; Venlafaxine Hydrochloride	2004
Venlafaxine XR and chronic pelvic pain syndrome. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:6 Topics: Adult; Chronic Disease; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Humans; Male; Pelvic Pain; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2004
Venlafaxine-associated hypomania in unipolar depression. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2004, Volume: 49, Issue:7 Topics: Adult; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Humans; Male; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Venlafaxine Hydrochloride	2004
[Vital functions at risk. Dealing with depressions rapidly and comprehensively]. MMW Fortschritte der Medizin, 2004, Apr-26, Volume: 146 Spec No 1 Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Comorbidity; Cyclohexanols; Depressive Disorder; HIV Infections; Humans; Long-Term Care; Randomized Controlled Trials as Topic; Sick Role; Venlafaxine Hydrochloride	2004
Serotonin syndrome due to association of venlafaxine, maprotiline and reboxetine. European psychiatry : the journal of the Association of European Psychiatrists, 2004, Volume: 19, Issue:7 Topics: Cyclohexanols; Depressive Disorder; Emergency Medical Services; Humans; Male; Maprotiline; Middle Aged; Morpholines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride	2004
Trazodone addition for insomnia in venlafaxine-treated, depressed inpatients: a semi-naturalistic study. Pharmacological research, 2005, Volume: 51, Issue:1 Topics: Adult; Chi-Square Distribution; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Prospective Studies; Sleep Initiation and Maintenance Disorders; Statistics, Nonparametric; Trazodone; Venlafaxine Hydrochloride	2005
Combination therapy with venlafaxine and carbamazepine in depressive patients not responding to venlafaxine: pharmacokinetic and clinical aspects. Journal of psychopharmacology (Oxford, England), 2004, Volume: 18, Issue:4 Topics: Adolescent; Adult; Aged; Alleles; Antidepressive Agents, Second-Generation; Carbamazepine; Cyclohexanols; Cytochrome P-450 CYP2D6; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Genotype; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride	2004
Combined antidepressant and hormone treatment is effective for chemotherapy-induced menopausal syndrome. European psychiatry : the journal of the Association of European Psychiatrists, 2005, Volume: 20, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Contraceptives, Oral, Synthetic; Cyclohexanols; Depressive Disorder; Drug-Related Side Effects and Adverse Reactions; Estrogens; Female; Follicle Stimulating Hormone; Humans; Lymphoma, B-Cell; Medroxyprogesterone; Menopause, Premature; Panic Disorder; Psychiatric Status Rating Scales; Severity of Illness Index; Venlafaxine Hydrochloride	2005
Increased libido with the combined use of venlafaxine and mirtazapine. Journal of clinical psychopharmacology, 2005, Volume: 25, Issue:2 Topics: Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Libido; Mianserin; Middle Aged; Mirtazapine; Venlafaxine Hydrochloride	2005
Sertraline and venlafaxine: new indication. Prevention of recurrent depression: no advance. Prescrire international, 2005, Volume: 14, Issue:75 Topics: Antidepressive Agents; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Double-Blind Method; Drug Approval; France; Humans; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2005
A probabilistic cost-effectiveness analysis of escitalopram, generic citalopram and venlafaxine as a first-line treatment of major depressive disorder in the UK. Current medical research and opinion, 2005, Volume: 21, Issue:4 Topics: Antidepressive Agents, Second-Generation; Citalopram; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder; Health Care Costs; Humans; Primary Health Care; Treatment Outcome; United Kingdom; Venlafaxine Hydrochloride	2005
Serotonin transporter residual availability during long-term antidepressant therapy does not differentiate responder and nonresponder unipolar patients. Biological psychiatry, 2006, Feb-15, Volume: 59, Issue:4 Topics: Adult; Aging; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Female; Humans; Image Processing, Computer-Assisted; Male; Mianserin; Middle Aged; Mirtazapine; Radiopharmaceuticals; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Tomography, Emission-Computed, Single-Photon; Tropanes; Venlafaxine Hydrochloride	2006
Cost-effectiveness of outpatient treatment in depressive patients with escitalopram in Germany. The European journal of health economics : HEPAC : health economics in prevention and care, 2005, Volume: 6, Issue:4 Topics: Ambulatory Care; Antidepressive Agents, Second-Generation; Citalopram; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder; Drug Costs; Drug Utilization; Germany; Health Care Surveys; Humans; Markov Chains; Models, Econometric; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2005
Moving beyond balance for a better antidepressant. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2005, Dec-01, Volume: 62, Issue:23 Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder; Duloxetine Hydrochloride; Humans; Neurotransmitter Uptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride	2005
Venlafaxine extended-release in patients older than 80 years with depressive syndrome. International journal of geriatric psychiatry, 2006, Volume: 21, Issue:4 Topics: Aged, 80 and over; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Female; Humans; Male; Primary Health Care; Prospective Studies; Remission Induction; Spain; Treatment Outcome; Venlafaxine Hydrochloride	2006
Repetitive transcranial magnetic stimulation (rTMS) in a patient suffering from comorbid depression and panic disorder following a myocardial infarction. Progress in neuro-psychopharmacology & biological psychiatry, 2006, Volume: 30, Issue:5 Topics: Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Citalopram; Clorazepate Dipotassium; Cyclohexanols; Depressive Disorder; Humans; Male; Middle Aged; Myocardial Infarction; Panic Disorder; Psychiatric Status Rating Scales; Transcranial Magnetic Stimulation; Venlafaxine Hydrochloride	2006
Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus. Hippocampus, 2006, Volume: 16, Issue:6 Topics: Animals; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Cell Proliferation; Chronic Disease; Cyclohexanols; Depressive Disorder; Dibenzothiazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Hippocampus; Neuronal Plasticity; Neurons; Quetiapine Fumarate; Rats; Restraint, Physical; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Stem Cells; Stress, Psychological; Venlafaxine Hydrochloride	2006
[Not neglecting therapy of depression in the elderly]. MMW Fortschritte der Medizin, 2006, Apr-20, Volume: 148, Issue:16 Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Somatoform Disorders; Venlafaxine Hydrochloride	2006
Acute adverse cutaneous reaction after the concomitant use of venlafaxine and orphenadrine citrate plus paracetamol in a depressed patient. Journal of the European Academy of Dermatology and Venereology : JEADV, 2006, Volume: 20, Issue:8 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Drug Combinations; Drug Eruptions; Drug Interactions; Female; Humans; Middle Aged; Muscle Relaxants, Central; Orphenadrine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2006
[Unipolar depression suddenly switches to hypomania in a patient who has just started taking venlafaxine]. Tijdschrift voor psychiatrie, 2006, Volume: 48, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Humans; Paroxetine; Treatment Outcome; Venlafaxine Hydrochloride	2006
NICE guidelines on antidepressants. The British journal of general practice : the journal of the Royal College of General Practitioners, 2006, Volume: 56, Issue:531 Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder; Drug Overdose; Family Practice; Guideline Adherence; Humans; Practice Guidelines as Topic; Practice Patterns, Physicians'; Venlafaxine Hydrochloride	2006
Venlafaxine for treatment of interferon alfa-induced depression. The Annals of pharmacotherapy, 2006, Volume: 40, Issue:11 Topics: Adult; Cyclohexanols; Depressive Disorder; Humans; Interferon-alpha; Male; Venlafaxine Hydrochloride	2006
Prescribing of venlafaxine and dosulepin in primary care. Journal of psychopharmacology (Oxford, England), 2006, Volume: 20, Issue:6 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Dothiepin; Guidelines as Topic; Humans; Primary Health Care; Suicide; Venlafaxine Hydrochloride	2006
Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates. Pediatrics, 2007, Volume: 119, Issue:1 Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depressive Disorder; Female; Humans; Infant Behavior; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Male; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Third; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2007
The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients. Postgraduate medicine, 2001, Volume: Spec No Pharmacotherapy Topics: Aged; Antidepressive Agents; Combined Modality Therapy; Cyclohexanols; Depressive Disorder; Humans; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2001
False positive phencyclidine results caused by venlafaxine. The American journal of psychiatry, 2007, Volume: 164, Issue:2 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Diagnosis, Differential; Drug Interactions; False Positive Reactions; Female; Humans; Middle Aged; Phencyclidine; Phencyclidine Abuse; Psychotic Disorders; Substance Abuse Detection; Venlafaxine Hydrochloride	2007
Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness. Journal of psychopharmacology (Oxford, England), 2007, Volume: 21, Issue:2 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Male; Medical Audit; Mianserin; Middle Aged; Mirtazapine; Retrospective Studies; Venlafaxine Hydrochloride; Weight Gain	2007
Onset of confusion in the context of late-life depression. Journal of psychiatry & neuroscience : JPN, 2007, Volume: 32, Issue:2 Topics: Aged; Confusion; Cyclohexanols; Depressive Disorder; Diagnosis, Differential; Dose-Response Relationship, Drug; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Memory Disorders; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2007
STARD level IV methodology. The American journal of psychiatry, 2007, Volume: 164, Issue:4* Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Humans; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Research Design; Tranylcypromine; Treatment Outcome; Venlafaxine Hydrochloride	2007
Venlafaxine hyponatraemia: incidence, mechanism and management. The Australian and New Zealand journal of psychiatry, 2007, Volume: 41, Issue:5 Topics: Age Factors; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cross-Sectional Studies; Cyclohexanols; Depressive Disorder; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Incidence; Prospective Studies; Risk Factors; Sodium; Venlafaxine Hydrochloride	2007
Antidepressant use and off-label prescribing in children and adolescents in Dutch general practice (2001-2005). Pharmacoepidemiology and drug safety, 2007, Volume: 16, Issue:9 Topics: Adolescent; Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Child; Cyclohexanols; Depressive Disorder; Drug Labeling; Drug Prescriptions; Drug Utilization; Family Practice; Female; Humans; Imipramine; Male; Netherlands; Nocturnal Enuresis; Paroxetine; Practice Patterns, Physicians'; Selective Serotonin Reuptake Inhibitors; Tension-Type Headache; Time Factors; Venlafaxine Hydrochloride	2007
Severe hypoglycemia following venlafaxine intoxication: a case report. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Antidotes; Blood Glucose; Charcoal; Creatine Kinase; Critical Care; Cyclohexanols; Depressive Disorder; Glasgow Coma Scale; Humans; Hypnotics and Sedatives; Hypoglycemia; Male; Oxazepam; Respiration, Artificial; Stress Disorders, Post-Traumatic; Suicide, Attempted; Venlafaxine Hydrochloride	2007
Cardiovascular changes associated with venlafaxine in the treatment of late-life depression. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2007, Volume: 15, Issue:8 Topics: Aged; Antidepressive Agents, Second-Generation; Blood Pressure; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Electrocardiography; Female; Heart Rate; Humans; Male; Nortriptyline; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride	2007
[Palinopsia following discontinuation of venlafaxine]. Psychiatrische Praxis, 2008, Volume: 35, Issue:5 Topics: Adult; Afterimage; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Humans; Perceptual Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride; Visual Perception	2008
Gingival bleeding due to venlafaxine. The Annals of pharmacotherapy, 2008, Volume: 42, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Gingival Hemorrhage; Humans; Male; Risk Factors; Venlafaxine Hydrochloride	2008
Depressed patients perception of the efficacy of electroconvulsive therapy and venlafaxine therapy. Neuro endocrinology letters, 2007, Volume: 28, Issue:6 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Electroconvulsive Therapy; Female; Humans; Male; Middle Aged; Patient Satisfaction; Psychiatric Status Rating Scales; Retrospective Studies; Self-Assessment; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride	2007
Change in pain severity with open label venlafaxine use in patients with a depressive symptomatology: an observational study in primary care. European psychiatry : the journal of the Association of European Psychiatrists, 2008, Volume: 23, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Chronic Disease; Comorbidity; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pain; Pain Measurement; Pain Threshold; Primary Health Care; Somatoform Disorders; Switzerland; Treatment Outcome; Venlafaxine Hydrochloride	2008
Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression. The Australian and New Zealand journal of psychiatry, 2008, Volume: 42, Issue:4 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cohort Studies; Cyclohexanols; Depressive Disorder; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Prospective Studies; Psychiatric Status Rating Scales; Remission Induction; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride	2008
[Microscopic colitis associated with celiac disease probably triggered by the administration of venlafaxine]. La Revue de medecine interne, 2009, Volume: 30, Issue:1 Topics: Aged; Antidepressive Agents, Second-Generation; Biopsy; Celiac Disease; Colitis, Microscopic; Colon; Colonoscopy; Cyclohexanols; Depressive Disorder; Humans; Male; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2009
Venlafaxine: a novel antidepressant. Journal of psychosocial nursing and mental health services, 1995, Volume: 33, Issue:1 Topics: Antidepressive Agents, Second-Generation; Caregivers; Cyclohexanols; Depressive Disorder; Female; Humans; Middle Aged; Stress, Psychological; Treatment Outcome; Venlafaxine Hydrochloride	1995
Venlafaxine: a new antidepressant drug. The Nurse practitioner, 1994, Volume: 19, Issue:9 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Venlafaxine Hydrochloride	1994
Venlafaxine for treatment-resistant unipolar depression. Journal of clinical psychopharmacology, 1994, Volume: 14, Issue:6 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Personality Assessment; Personality Inventory; Treatment Outcome; Venlafaxine Hydrochloride	1994
Treatment option for depression offered in the United States. Journal of psychosocial nursing and mental health services, 1994, Volume: 32, Issue:7 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Drug Approval; Humans; United States; Venlafaxine Hydrochloride	1994
Venlafaxine--a new antidepressant. The Medical letter on drugs and therapeutics, 1994, Jun-10, Volume: 36, Issue:924 Topics: Antidepressive Agents; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Humans; Neurotransmitter Uptake Inhibitors; Venlafaxine Hydrochloride	1994
Venlafaxine: a new dimension in antidepressant pharmacotherapy. The Journal of clinical psychiatry, 1993, Volume: 54, Issue:3 Topics: Ambulatory Care; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Hospitalization; Humans; Venlafaxine Hydrochloride	1993
Possible venlafaxine withdrawal syndrome. The American journal of psychiatry, 1996, Volume: 153, Issue:4 Topics: Adult; Cyclohexanols; Depressive Disorder; Fatigue; Female; Gastrointestinal Diseases; Headache; Humans; Nausea; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Tinnitus; Venlafaxine Hydrochloride	1996
Venlafaxine for the treatment of chronic pain. The American journal of psychiatry, 1996, Volume: 153, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Back Pain; Chronic Disease; Cyclohexanols; Depressive Disorder; Female; Humans; Pain; Treatment Outcome; Venlafaxine Hydrochloride	1996
Serotonin syndrome induced by administration of venlafaxine and phenelzine. The Annals of pharmacotherapy, 1996, Volume: 30, Issue:1 Topics: Antidepressive Agents; Central Nervous System Diseases; Cyclohexanols; Depressive Disorder; Humans; Male; Middle Aged; Phenelzine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Syndrome; Venlafaxine Hydrochloride	1996
Three new antidepressants. Drug and therapeutics bulletin, 1996, Volume: 34, Issue:9 Topics: Antidepressive Agents, Second-Generation; Citalopram; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Interactions; Humans; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride	1996
Venlafaxine withdrawal reactions. The American journal of psychiatry, 1996, Volume: 153, Issue:12 Topics: Cyclohexanols; Depressive Disorder; Dizziness; Female; Humans; Male; Middle Aged; Nausea; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	1996
Venlafaxine and ecchymosis. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1997, Volume: 42, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Blood Coagulation Tests; Cyclohexanols; Depressive Disorder; Ecchymosis; Female; Humans; Venlafaxine Hydrochloride	1997
Venlafaxine and urinary incontinence: possible association. The Annals of pharmacotherapy, 1997, Volume: 31, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Male; Middle Aged; Urinary Incontinence; Venlafaxine Hydrochloride	1997
Efficacy of papaverine addition for treatment-refractory major depression. The American journal of psychiatry, 1997, Volume: 154, Issue:4 Topics: Buspirone; Cyclohexanols; Depressive Disorder; Drug Resistance; Drug Therapy, Combination; Female; Humans; Lithium; Middle Aged; Papaverine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	1997
Venlafaxine-induced increased libido and spontaneous erections. The British journal of psychiatry : the journal of mental science, 1997, Volume: 170 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Libido; Male; Middle Aged; Penile Erection; Venlafaxine Hydrochloride	1997
Benztropine in the treatment of venlafaxine-induced sweating. The Journal of clinical psychiatry, 1997, Volume: 58, Issue:4 Topics: Benztropine; Cyclohexanols; Depressive Disorder; Female; Humans; Hyperhidrosis; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sweating; Venlafaxine Hydrochloride	1997
Channeling of three newly introduced antidepressants to patients not responding satisfactorily to previous treatment. Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:3 Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Drug Resistance; Drug Utilization; Humans; Mianserin; Middle Aged; Mirtazapine; Netherlands; Sertraline; Venlafaxine Hydrochloride	1997
Venlafaxine-induced hyponatremia. Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:3 Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Female; Humans; Hyponatremia; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	1997
Venlafaxine-induced reset osmostat syndrome: case of a 79-year-old depressed woman. Journal of geriatric psychiatry and neurology, 1997, Volume: 10, Issue:2 Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Diagnosis, Differential; Dose-Response Relationship, Drug; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Venlafaxine Hydrochloride; Water-Electrolyte Balance	1997
Dangerous interaction with nefazodone added to fluoxetine, desipramine, venlafaxine, valproate and clonazepam combination therapy. Journal of psychopharmacology (Oxford, England), 1997, Volume: 11, Issue:2 Topics: Adult; Antidepressive Agents; Clonazepam; Cyclohexanols; Depressive Disorder; Desipramine; Drug Therapy, Combination; Female; Fluoxetine; Humans; Hypotension; Panic Disorder; Piperazines; Substance Withdrawal Syndrome; Triazoles; Venlafaxine Hydrochloride	1997
Suspected complication of treatment with venlafaxine. Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:4 Topics: Adult; Antidepressive Agents; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Humans; Middle Aged; Research Design; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	1997
Venlafaxine-fluoxetine-nortriptyline interaction. Journal of psychiatry & neuroscience : JPN, 1997, Volume: 22, Issue:4 Topics: Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Nortriptyline; Venlafaxine Hydrochloride	1997
Withdrawal syndrome after discontinuation of venlafaxine. The American journal of psychiatry, 1997, Volume: 154, Issue:10 Topics: Age Factors; Aged; Cyclohexanols; Depressive Disorder; Female; Gastrointestinal Diseases; Headache; Humans; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	1997
Clinical considerations in managing nausea associated with venlafaxine. Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:6 Topics: Antidepressive Agents, Second-Generation; Cisapride; Cyclohexanols; Depressive Disorder; Gastrointestinal Agents; Humans; Nausea; Piperidines; Venlafaxine Hydrochloride	1997
Seizure activity and enzyme elevations after venlafaxine overdose. Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:6 Topics: Adult; Antidepressive Agents, Second-Generation; Creatine Kinase; Cyclohexanols; Depressive Disorder; Drug Overdose; Humans; L-Lactate Dehydrogenase; Male; Seizures; Suicide, Attempted; Venlafaxine Hydrochloride	1997
Severe anticholinergic side effects with venlafaxine-fluoxetine combination. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1997, Volume: 42, Issue:9 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Middle Aged; Receptors, Cholinergic; Venlafaxine Hydrochloride	1997
Functional magnetic resonance imaging studies of emotional processing in normal and depressed patients: effects of venlafaxine. The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 16 Topics: Adolescent; Adult; Brain; Cyclohexanols; Depressive Disorder; Echo-Planar Imaging; Emotions; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride; Visual Cortex; Visual Perception	1997
Breast enlargement during chronic antidepressant therapy. Journal of affective disorders, 1997, Volume: 46, Issue:2 Topics: Breast; Breast Diseases; Cyclohexanols; Depressive Disorder; Female; Fluoxetine; Humans; Hyperplasia; Male; Menopause; Paroxetine; Prolactin; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Weight Gain	1997
Remission of traumatic brain injury-induced compulsions during venlafaxine treatment. General hospital psychiatry, 1998, Volume: 20, Issue:1 Topics: Antidepressive Agents, Second-Generation; Craniotomy; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Head Injuries, Closed; Hematoma, Epidural, Cranial; Humans; Male; Middle Aged; Neurocognitive Disorders; Obsessive-Compulsive Disorder; Postoperative Complications; Recurrence; Venlafaxine Hydrochloride	1998
Anticholinergic toxic syndrome with venlafaxine-desipramine combination. Pharmacopsychiatry, 1998, Volume: 31, Issue:1 Topics: Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cholinergic Antagonists; Cyclohexanols; Depressive Disorder; Desipramine; Drug Combinations; Humans; Male; Venlafaxine Hydrochloride	1998
Serotonin syndrome induced by venlafaxine and fluoxetine: a case study in polypharmacy and potential pharmacodynamic and pharmacokinetic mechanisms. The Annals of pharmacotherapy, 1998, Volume: 32, Issue:4 Topics: Adult; Cyclohexanols; Depressive Disorder; Drug Interactions; Female; Fluoxetine; Humans; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride	1998
Withdrawal reactions associated with venlafaxine. The Australian and New Zealand journal of psychiatry, 1998, Volume: 32, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hallucinations; Humans; Male; Risk Factors; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	1998
Venlafaxine drug-drug interactions in clinical practice. Journal of psychiatry & neuroscience : JPN, 1998, Volume: 23, Issue:3 Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Drug Interactions; Female; Humans; Male; Middle Aged; Venlafaxine Hydrochloride	1998
Synergistic benefits of serotonin and noradrenaline reuptake inhibition. Depression and anxiety, 1998, Volume: 7 Suppl 1 Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Mianserin; Mirtazapine; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride	1998
Venlafaxine withdrawal syndrome. Australian and New Zealand journal of medicine, 1998, Volume: 28, Issue:2 Topics: Cyclohexanols; Depressive Disorder; Electroconvulsive Therapy; Humans; Male; Middle Aged; Nausea; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	1998
Venlafaxine augmentation with methylphenidate for treatment-refractory depression: a case report. Journal of clinical psychopharmacology, 1998, Volume: 18, Issue:3 Topics: Aged; Antidepressive Agents, Second-Generation; Central Nervous System Stimulants; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Humans; Male; Methylphenidate; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	1998
Venlafaxine withdrawal reactions. The Medical journal of Australia, 1998, Jul-20, Volume: 169, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Cyclohexanols; Depression; Depressive Disorder; Dizziness; Fatigue; Female; Hallucinations; Headache; Humans; Male; Middle Aged; Nausea; Sensation Disorders; Substance Withdrawal Syndrome; Tinnitus; Venlafaxine Hydrochloride	1998
Venlafaxine: loss of antidepressant effect and its management. The Journal of clinical psychiatry, 1998, Volume: 59, Issue:7 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Recurrence; Venlafaxine Hydrochloride	1998
Breast pain associated with venlafaxine. The Journal of clinical psychiatry, 1996, Volume: 57, Issue:9 Topics: Adult; Breast; Breast Diseases; Cyclohexanols; Depressive Disorder; Edema; Female; Humans; Male; Pain; Selective Serotonin Reuptake Inhibitors; Sex Factors; Venlafaxine Hydrochloride	1996
Treatment of venlafaxine discontinuation symptoms with ondansetron. The Journal of clinical psychiatry, 1998, Volume: 59, Issue:11 Topics: Adult; Cyclohexanols; Depressive Disorder; Female; Humans; Ondansetron; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	1998
Venlafaxine-tramadol similarities. Medical hypotheses, 1998, Volume: 51, Issue:2 Topics: Analgesics, Opioid; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Models, Biological; Models, Psychological; Molecular Structure; Pain; Structure-Activity Relationship; Tramadol; Venlafaxine Hydrochloride	1998
Prolonged bradycardia complicates antidepressive treatment with venlafaxine and ECT. The British journal of psychiatry : the journal of mental science, 1998, Volume: 173 Topics: Adult; Antidepressive Agents, Second-Generation; Bradycardia; Combined Modality Therapy; Cyclohexanols; Depressive Disorder; Electroconvulsive Therapy; Humans; Male; Venlafaxine Hydrochloride	1998
Venlafaxine-fluoxetine interaction. Journal of clinical psychopharmacology, 1999, Volume: 19, Issue:1 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Cholinergic Antagonists; Cyclohexanols; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Treatment Outcome; Venlafaxine Hydrochloride	1999
A study involving venlafaxine overdoses: comparison of fatal and therapeutic concentrations in postmortem specimens. Journal of forensic sciences, 1999, Volume: 44, Issue:1 Topics: Adult; Alcoholism; Antidepressive Agents, Second-Generation; Autopsy; Cyclohexanols; Depressive Disorder; Drug Overdose; Female; Humans; Substance Abuse Detection; Venlafaxine Hydrochloride	1999
Combination treatment with venlafaxine and bupropion. The American journal of psychiatry, 1999, Volume: 156, Issue:3 Topics: Adult; Bupropion; Cyclohexanols; Depressive Disorder; Dopamine Uptake Inhibitors; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	1999
Redefining antidepressant efficacy toward long-term recovery. The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 6 Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Goals; Humans; Imipramine; Longitudinal Studies; Placebos; Risk Factors; Secondary Prevention; Treatment Outcome; Venlafaxine Hydrochloride	1999
Mergers and acquisitions among psychotropics: antidepressant takeover of anxiety may now be complete. The Journal of clinical psychiatry, 1999, Volume: 60, Issue:5 Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Drug Approval; Humans; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	1999
Spontaneous erections and libido increase associated with venlafaxine. European journal of neurology, 1999, Volume: 6, Issue:4 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Libido; Male; Middle Aged; Parkinson Disease; Penile Erection; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride	1999
Venlafaxine and bupropion combination therapy in a case of treatment-resistant depression. The Annals of pharmacotherapy, 1999, Volume: 33, Issue:6 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Chronic Disease; Cyclohexanols; Depressive Disorder; Drug Resistance; Drug Therapy, Combination; Female; Humans; Psychiatric Status Rating Scales; Recurrence; Venlafaxine Hydrochloride	1999
[Proofs of efficacy]. L'Encephale, 1999, Volume: 25 Spec No 2 Topics: Antidepressive Agents, Tricyclic; Clomipramine; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Fluoxetine; Humans; Norepinephrine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	1999
Venlafaxine versus fluoxetine. The Journal of clinical psychiatry, 1999, Volume: 60, Issue:10 Topics: Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Randomized Controlled Trials as Topic; Research Design; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	1999
Adjunctive lamotrigine treatment for major depression. The American journal of psychiatry, 1999, Volume: 156, Issue:11 Topics: Adult; Antidepressive Agents; Clonazepam; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Lamotrigine; Lithium Carbonate; Middle Aged; Treatment Outcome; Triazines; Venlafaxine Hydrochloride	1999
Once-daily venlafaxine XR compared with fluoxetine in outpatients with depression and anxiety. The Journal of clinical psychiatry, 1999, Volume: 60, Issue:11 Topics: Anxiety Disorders; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Fluoxetine; Humans; Neurotransmitter Uptake Inhibitors; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	1999
Effect of subchronic antidepressant treatments on behavioral, neurochemical, and endocrine changes in the forced-swim test. Pharmacology, biochemistry, and behavior, 2000, Volume: 65, Issue:4 Topics: Amygdala; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior, Animal; Biogenic Amines; Brain Chemistry; Cerebral Cortex; Corticosterone; Cyclohexanols; Depressive Disorder; Desipramine; Hormones; Hypothalamo-Hypophyseal System; Male; Motor Activity; Paroxetine; Rats; Rats, Sprague-Dawley; Serotonin; Swimming; Venlafaxine Hydrochloride	2000
Drug therapy in treatment-resistant depression. The British journal of psychiatry : the journal of mental science, 1999, Volume: 175 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	1999
Newer antidepressants: a comparison of tolerability in general practice. The British journal of general practice : the journal of the Royal College of General Practitioners, 1999, Volume: 49, Issue:448 Topics: Adult; Aged; Antidepressive Agents; Cohort Studies; Cyclohexanols; Depressive Disorder; Family Practice; Female; Fluoxetine; Humans; Male; Middle Aged; Moclobemide; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride	1999
Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine. The Journal of clinical psychiatry, 2000, Volume: 61, Issue:4 Topics: Adult; Cyclohexanols; Depressive Disorder; Female; Humans; Libido; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Ontario; Orgasm; Paroxetine; Prevalence; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Sexual Dysfunctions, Psychological; Treatment Outcome; Venlafaxine Hydrochloride	2000
One-year costs of second-line therapies for depression. The Journal of clinical psychiatry, 2000, Volume: 61, Issue:4 Topics: Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cohort Studies; Comorbidity; Cyclohexanols; Depressive Disorder; Drug Costs; Female; Health Care Costs; Health Expenditures; Health Services; Humans; Independent Practice Associations; Male; Multivariate Analysis; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2000
Marked increase of venlafaxine enantiomer concentrations as a consequence of metabolic interactions: a case report. Pharmacopsychiatry, 2000, Volume: 33, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Biotransformation; Cyclohexanols; Cytochrome P-450 CYP2D6; Depressive Disorder; Drug Interactions; Humans; Male; Stereoisomerism; Venlafaxine Hydrochloride	2000
SIADH with multiple antidepressants in a geriatric patient. The Journal of clinical psychiatry, 2000, Volume: 61, Issue:6 Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Bupropion; Cyclohexanols; Depressive Disorder; Humans; Inappropriate ADH Syndrome; Mianserin; Mirtazapine; Risperidone; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2000
Agranulocytosis during treatment with mianserin and venlafaxine. Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:4 Topics: Aged; Agranulocytosis; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Mianserin; Venlafaxine Hydrochloride	2000
Reduced testosterone level in a venlafaxine treated patient. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2000, Volume: 12, Issue:3 Topics: Adult; Cyclohexanols; Depressive Disorder; Humans; Male; Selective Serotonin Reuptake Inhibitors; Testosterone; Venlafaxine Hydrochloride	2000
Effective treatment of venlafaxine-induced noncyclical mastalgia with bromocriptine. Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:5 Topics: Antidepressive Agents, Second-Generation; Breast Diseases; Bromocriptine; Cyclohexanols; Depressive Disorder; Dopamine Agonists; Female; Humans; Middle Aged; Pain; Venlafaxine Hydrochloride	2000
Review of the pharmacokinetics, pharmacogenetics, and drug interaction potential of antidepressants: focus on venlafaxine. Depression and anxiety, 2000, Volume: 12 Suppl 1 Topics: Aged; Cyclohexanols; Cytochrome P-450 Enzyme System; Depressive Disorder; Drug Interactions; Drug Tolerance; Female; Genotype; Half-Life; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2000
Venlafaxine versus sertraline for major depressive disorder. The Journal of clinical psychiatry, 2000, Volume: 61, Issue:11 Topics: Ambulatory Care; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Randomized Controlled Trials as Topic; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	2000
Serotonergic antidepressants and urinary incontinence. International urogynecology journal and pelvic floor dysfunction, 2000, Volume: 11, Issue:6 Topics: Adult; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Female; Humans; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Urinary Incontinence; Venlafaxine Hydrochloride	2000
Fluoxetine (Sarafem) for premenstrual dysphoric disorder. The Medical letter on drugs and therapeutics, 2001, Jan-22, Volume: 43, Issue:1096 Topics: Adult; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoxetine; Humans; Nausea; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride; Weight Gain	2001
Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio. Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:2 Topics: 5-Hydroxytryptophan; Adult; Analysis of Variance; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Female; Fluoxetine; Humans; Imipramine; Interferon-gamma; Interleukin-10; Male; Middle Aged; Venlafaxine Hydrochloride	2001
Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunction. The Journal of clinical psychiatry, 2001, Volume: 62, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Sexual Dysfunctions, Psychological; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride	2001
Recurrent depression with vagus nerve stimulation. The American journal of psychiatry, 2001, Volume: 158, Issue:5 Topics: Anticonvulsants; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Cyclohexanols; Depressive Disorder; Electric Stimulation Therapy; Epilepsy; Humans; Male; Middle Aged; Vagus Nerve; Venlafaxine Hydrochloride	2001
Problems with ensuring a double blind. The Journal of clinical psychiatry, 2001, Volume: 62, Issue:4 Topics: Cyclohexanols; Delusions; Depressive Disorder; Double-Blind Method; Fluvoxamine; Humans; Randomized Controlled Trials as Topic; Research Design; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2001
Venlafaxine-induced hair loss. The American journal of psychiatry, 2001, Volume: 158, Issue:7 Topics: Alopecia; Cyclohexanols; Depressive Disorder; Female; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2001
Functional brain circuits in major depression and remission. Archives of general psychiatry, 2001, Volume: 58, Issue:7 Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Brain; Cyclohexanols; Depressive Disorder; Glucose; Humans; Neural Pathways; Psychotherapy; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Venlafaxine Hydrochloride	2001
Neuroimaging profiles and the differential therapies of depression. Archives of general psychiatry, 2001, Volume: 58, Issue:7 Topics: Antidepressive Agents; Brain; Cyclohexanols; Depressive Disorder; Fluorodeoxyglucose F18; Glucose; Humans; Psychotherapy; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Venlafaxine Hydrochloride	2001
Topiramate in venlafaxine-induced visual hallucinations in an obese patient with a posterior cerebral artery infarction. Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:4 Topics: Agoraphobia; Alcoholism; Cyclohexanols; Depressive Disorder; Female; Fructose; Hallucinations; Humans; Infarction, Posterior Cerebral Artery; Middle Aged; Neuroprotective Agents; Obesity; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Topiramate; Venlafaxine Hydrochloride	2001
[Depressive disorders and antidepressive therapy. A comparison of neurology practice and psychiatric clinic]. Der Nervenarzt, 2001, Volume: 72, Issue:7 Topics: Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug Utilization; Female; Hospitals, Psychiatric; Humans; Male; Middle Aged; Neurology; Patient Admission; Patient Care Team; Treatment Outcome; Venlafaxine Hydrochloride	2001
Flushing in a menopausal woman taking venlafaxine. The American journal of psychiatry, 2001, Volume: 158, Issue:8 Topics: Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Estrogens, Conjugated (USP); Female; Flushing; Hot Flashes; Humans; Menopause; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2001
Venlafaxine in the treatment of postpartum depression. The Journal of clinical psychiatry, 2001, Volume: 62, Issue:8 Topics: Adult; Anxiety Disorders; Cyclohexanols; Depression, Postpartum; Depressive Disorder; Drug Administration Schedule; Female; Humans; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride	2001
Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study. The American journal of psychiatry, 2001, Volume: 158, Issue:10 Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Abortion, Therapeutic; Birth Weight; Cyclohexanols; Depressive Disorder; Female; Gestational Age; Humans; Infant, Newborn; Maternal Exposure; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimester, First; Prospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Smoking; Venlafaxine Hydrochloride	2001
Addition of olanzapine for treatment-resistant depression. The American journal of psychiatry, 2001, Volume: 158, Issue:10 Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Olanzapine; Pirenzepine; Treatment Outcome; Venlafaxine Hydrochloride	2001
Once-daily venlafaxine extended release (XR) vs. fluoxetine for the treatment of depression. Journal of affective disorders, 2001, Volume: 66, Issue:1 Topics: Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Fluoxetine; Half-Life; Humans; Treatment Outcome; Venlafaxine Hydrochloride	2001
Venlafaxine- and trazodone-induced serotonin syndrome. The American journal of psychiatry, 2001, Volume: 158, Issue:12 Topics: Cyclohexanols; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Humans; Male; Middle Aged; Serotonin Syndrome; Trazodone; Venlafaxine Hydrochloride	2001
Consensus guidelines outline drug selection and sequencing options for bipolar disorder. Report on medical guidelines & outcomes research, 2000, May-11, Volume: 11, Issue:10 Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Humans; Lithium; Practice Guidelines as Topic; Valproic Acid	2000
Sertralilne, paroxetine and venlafaxine in refugee post traumatic stress disorder with depression symptoms. Medicinski arhiv, 2001, Volume: 55, Issue:1 Suppl 1 Topics: Adult; Antidepressive Agents; Bosnia and Herzegovina; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Pilot Projects; Refugees; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; United States; Venlafaxine Hydrochloride; Warfare	2001
Serotonin syndrome caused by selective serotonin reuptake-inhibitors-metoclopramide interaction. The Annals of pharmacotherapy, 2002, Volume: 36, Issue:1 Topics: Accidental Falls; Adult; Aged; Basal Ganglia Diseases; Cyclohexanols; Depressive Disorder; Dopamine Antagonists; Drug Interactions; Female; Humans; Metoclopramide; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sertraline; Tibial Fractures; Venlafaxine Hydrochloride	2002
A 75-year-old man with depression. JAMA, 2002, Mar-27, Volume: 287, Issue:12 Topics: Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Coronary Artery Bypass; Coronary Disease; Cyclohexanols; Depressive Disorder; Diagnosis, Differential; Family; Humans; Male; Prevalence; Psychotherapy; Retirement; United States; Venlafaxine Hydrochloride	2002
Hyponatraemia in elderly psychiatric patients treated with Selective Serotonin Reuptake Inhibitors and venlafaxine: a retrospective controlled study in an inpatient unit. International journal of geriatric psychiatry, 2002, Volume: 17, Issue:3 Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Female; Geriatric Assessment; Humans; Hyponatremia; Male; Middle Aged; Psychiatric Department, Hospital; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Victoria	2002
Prevalence of sexual dysfunction among newer antidepressants. The Journal of clinical psychiatry, 2002, Volume: 63, Issue:4 Topics: Adult; Antidepressive Agents; Attitude of Health Personnel; Attitude to Health; Cross-Sectional Studies; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Female; Humans; Logistic Models; Male; Physicians, Family; Prevalence; Primary Health Care; Prospective Studies; Research Design; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological; United States; Venlafaxine Hydrochloride	2002
Venlafaxine-associated vaginal bleeding. Pharmacotherapy, 2002, Volume: 22, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Female; Hemorrhage; Humans; Menstruation; Vaginal Diseases; Venlafaxine Hydrochloride	2002
Treatment costs of venlafaxine and selective serotonin-reuptake inhibitors for depression and anxiety. Managed care interface, 2002, Volume: 15, Issue:6 Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Cyclohexanols; Depressive Disorder; Drug Costs; Female; Health Care Costs; Humans; Longitudinal Studies; Male; Managed Care Programs; Middle Aged; Patient Compliance; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; United States; Venlafaxine Hydrochloride	2002
Rapid onset of antidepressant activity with venlafaxine. The Journal of clinical psychiatry, 2002, Volume: 63, Issue:6 Topics: Adult; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Humans; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride	2002
Coexisting major depression and obsessive-compulsive disorder treated with venlafaxine. Journal of clinical psychopharmacology, 1990, Volume: 10, Issue:2 Topics: Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Drugs, Investigational; Humans; Male; Obsessive-Compulsive Disorder; Venlafaxine Hydrochloride	1990
An open-label, dose-finding study of WY-45,030, a novel bicyclic antidepressant. Psychopharmacology bulletin, 1988, Volume: 24, Issue:1 Topics: Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Venlafaxine Hydrochloride	1988